WO1999055828A1 - Method for actively and selectively eliminating small molecules by enzymatic pumping: active dialysis - Google Patents
Method for actively and selectively eliminating small molecules by enzymatic pumping: active dialysis Download PDFInfo
- Publication number
- WO1999055828A1 WO1999055828A1 PCT/FR1999/000970 FR9900970W WO9955828A1 WO 1999055828 A1 WO1999055828 A1 WO 1999055828A1 FR 9900970 W FR9900970 W FR 9900970W WO 9955828 A1 WO9955828 A1 WO 9955828A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- membrane
- solute
- enzymatic
- liquid
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/18—Apparatus specially designed for the use of free, immobilized or carrier-bound enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
- A61M2202/0486—Glucose
Definitions
- the field of the present invention is that of the separation and elimination / purification of small molecules (solutes) in the liquid phase, by passage through a porous bioactive membrane. This is aimed at the depollution of a given liquid compartment by elimination of undesirable solutes or, more generally, the isolation of certain solutes which are not necessarily polluting but which may have high added value.
- These techniques for transporting ionic solutes or not by diffusion through a membrane, the role of which is to prevent convective transport of the solvent, are commonly known by the term dialysis.
- the invention therefore relates to a method of active and selective dialysis, assisted by enzymatic pumping of at least one solute S through at least one porous membrane separating at least partially two liquid compartments C, and C ⁇ , the transfer s operant of C, which one impoverishes in S towards C , which one consequently enriches in S.
- the invention also relates to a dialysis device assisted by enzymatic pumping, useful in particular for the implementation of the above-mentioned process.
- Passive transmembrane diffusion dialysis has been known for a long time. It has been the subject of numerous ad hoc applications in the chemical industry and in the food and pharmaceutical fields. It is essentially a slow operation which is conditioned by the existence of a concentration gradient on either side of the membrane for the solute (s) to be separated and / or eliminated. Dialysis has therefore proven to be relatively expensive on an industrial scale. This is how more radical processes, based on external driving forces (mechanical or electrical), have been much more studied and exploited, despite their higher energy cost. In fact, industrial dialysis only becomes competitive when these energy-consuming processes are ineffective, when they risk damaging the solute to be isolated or when the slowness of the dialysis operation does not constitute a handicap.
- Hemodialysis is a medical technique intended for subjects suffering from partial or total renal insufficiency. It consists of an extracorporeal treatment of the blood, ensuring the same functions as the kidney, thanks to a membrane process based on both dialysis and ultrafiltration. A less elegant solution than organ transplantation, it is essential given the disproportion between the number of potential donors and that of applicants.
- the small molecules that we seek to eliminate from blood on hemodialysis are urea, uric acid, creatinine and other metabolic wastes of low molecular weight. This elimination must be done selectively by allowing the treated blood to conserve the macromolecules and metabolites essential to these functions and by preserving its electrolytic and aqueous balance sheets.
- hemofiltration In addition to hemodialysis, hemofiltration is also known as a method of removing certain undesirable solutes from the blood.
- the principle of hemofiltration consists in using filtration as a motor for the exchange of solutes. Hemofiltration allows good purification of medium molecules.
- the blood is purified passively (hemodialysis) or by creating a slight pressure difference between the blood circulating in the lumen of hollow fibers and a liquid called dialysate circulating outside the fibers (hemofiltration).
- passive or induced diffusion does not differentiate between them the small molecules contained in the blood, depending on whether they are harmful and therefore to be eliminated or essential and therefore to be preserved.
- one of the essential objectives of the present invention is to improve the known techniques of separation or elimination of certain solutes by transmembrane diffusion, by providing a method of forced dialysis making it possible to lower consequently quickly and selectively the level of concentration of a solute in a given liquid compartment, by transferring it through a membrane into another liquid compartment, whatever the level of concentration of the solute considered in this latter compartment, c that is to say even in the absence of a concentration gradient favorable to a diffusion flow from the most concentrated compartment to the least concentrated compartment.
- Another essential objective of the invention is to provide a method of forced dialysis making it possible to extract, for example for the purpose of depollution, purification or isolation, a given solute by implementing a transmembrane diffusion having significantly kinetic superior to that of a conventional passive transmembrane diffusion process.
- Another essential objective of the present invention is to provide a method of differential and therefore selective forced dialysis for one or more solutes.
- Another essential objective of the present invention is to provide a simple, rapid and economical dialysis process.
- Another essential objective of the present invention is to provide a selective and rapid dialysis process which makes it possible to dispense with the use of large quantities of dialysates hitherto useful for generating concentration gradients necessary for passive diffusion.
- Another essential objective of the present invention is to provide a simple, selective, rapid, economical dialysis process which can be applied in hemodialysis in an efficient manner.
- Another essential objective of the present invention is to provide a dialysis device capable of allowing in particular the implementation of the abovementioned process.
- Another essential objective of the invention is to provide a simple, economical, selective and rapid dialysis device.
- Such an enzymatic system can comprise at least one pair of reverse enzymes, one of the enzymes of the pair being fixed on one side of the membrane, while the other enzyme is immobilized on the other side of this membrane, these enzymes being, in addition, possibly contained in the liquid medium of the compartments, with the exclusion of the porous enzymatic diffusion membrane.
- This system behaves like a pump which generates and maintains a difference in concentration of solute (s) to be transferred between the two compartments.
- the present invention relates first of all to a dialysis process assisted by enzymatic pumping of at least one solute S through at least one porous membrane separating at least partially two liquid compartments C, and C ,, , (S being referenced S, in C, and S ,, in C ,,), this dialysis taking place from the liquid compartment C, which we aim to deplete in S, towards the liquid compartment C ⁇ intended consequently for s '' enrich in S, characterized in that it consists essentially and successively or not:
- the innovative technical principle which governs the process according to the invention can be assimilated to an enzymatic pumping mechanism making it possible to transfer a solute S in a compartment (I) starting liquid, to a compartment (II) arriving liquid, by active transport through an porous enzymatic membrane.
- the solute S thus accumulates and concentrates in the arrival compartment, even if the concentration of the solute in the latter is higher than that of S in the departure compartment.
- Such an enzymatic pumping process is particularly advantageous since it allows rapid and selective elimination of one or more solutes from a liquid compartment Ci, for example blood (hemodialysis), without using large volumes of dialysate. C ⁇ without excessive energy consumption.
- This enzymatic pump essentially only requires chemical energy, which can be provided, for example, by molecules with an energy-rich bond, such as adenosine triphosphate (ATP).
- ATP adenosine triphosphate
- the kinetic gain provided by the invention remains compatible with the duration threshold below which a blood stress is generated in the hemodialysis application.
- the new and innovative approach according to the invention therefore consisted, firstly, of understanding and explaining the biological phenomenon and, secondly, of reproducing it (mimicry) by adapting it to medical or industrial separation specifications / elimination of chemical compounds, particularly for the purposes of elimination and isolation of toxic compounds, or for the recovery of molecules with high added value: chemical, pharmaceutical, cosmetic or others.
- the enzyme E ⁇ which governs the production of S ⁇ is selected on the one hand and, on the other hand, the porous membrane, so that the latter is impermeable to S ⁇ II and thus prevents, at least partially, the diffusion of S ⁇ I , from C ⁇ to C ,; S ⁇ II and the membrane thus being preferably entities of electric charges of the same sign.
- S ⁇ II results from the action of the enzyme E ⁇ on the neutral substrate S ⁇ .
- the electrical charge of the faces of the porous membrane can be obtained, for example, by immobilizing, on the membrane, the enzymes E ⁇ and E p and polyamino acids, the pK of which give the membrane, for a given pH, negative or positive charges.
- the polyamino acid is eg polylysine
- the membrane is positively charged at pH 9
- a polyamino acid corresponding eg to a polyglutamate the membrane is negatively charged at pH 9.
- membranes can be chosen whose zeta potential at the optimum pH is adapted to given conditions of the process of the invention.
- a first variant is provided for. process according to the invention in which:
- At least one porous membrane comprising on and / or in its face F, opposite C , at least one enzyme E p capable of catalyzing the reaction of transformation of the solute-primary product S ⁇ I resulting from the diffusion through the membrane of S ⁇ II from C Painto C, in solute-secondary product S ⁇ ,
- E p could be carried by an annex membrane and / or on any other solid support dispersed or not in C, according to a second variant of the method according to the invention:
- Edi, Ed ⁇ are between 50 and 500 micrometers, depending on the hydrodynamic conditions imposed.
- the second variant corresponds to the preferred embodiment of the invention, which combines the advantages of an enzymatic pumping system comprising two reversible enzymes fixed, respectively, one and the other on the opposite faces of a membrane porous diffusion and a third active enzyme in compartment C readilyintended to enrich in solute S diffusing through the membrane.
- This third enzyme E ⁇ is preferably (just like E p ) the inverse enzyme of the enzyme E ⁇ of C ,,.
- the enzyme E ⁇ is advantageously contained in C ⁇ on a support other than the face F ⁇ of the membrane.
- E ⁇ can thus be, for example, fixed on an annex membrane or any other suitable support immersed in C ,, or even be dispersed in C ⁇ .
- the retransformation in C, and C ⁇ of the enzymatic metabolites resulting from the enzymatic reactions with E ⁇ and Ep, in solutes S, and / or S ,, optimizes the pumping effect.
- We can further complete this by giving the membrane a valve effect compared to the S ⁇ I1 metabolites produced in C ,,, to prevent the latter from re- diffusing in C ,.
- the result of the enzymatic pumping according to the invention is the transfer of S, from C, into C ,,. Once this result has been achieved, it is easy to recover S ,, for the purpose of elimination or recovery.
- the enzymatic membrane is in the form of a monolayer or multilayer film, preferably substantially planar.
- This discontinuous mode corresponds, for example, to the case in which there is a reactor formed by a first container containing the liquid medium in which a second container is at least partially immersed. The submerged part of this second container being constituted at least in part by the porous enzymatic membrane.
- These two containers define compartments C, and C ⁇ .
- the membrane can form all or part of the wall of the container. Preferably, this membrane constitutes a substantially flat part of the partition wall between the two compartments C, and C ,,.
- the enzymatic membrane is in tubular form and more precisely constitutes all or part of the wall of a tube, the lumen of which forms one of the compartments C,.
- the enzymatic membrane can be made of a plurality of hollow fibers or tubular membranes, preferably united in bundle (x).
- the pH and temperature parameters of the liquid media are adjusted, so as to obtain an optimum in kinetics and in yield for the enzymatic transformations by E ⁇ and E p , or even E ⁇ .
- the liquid medium of C, and / or C ⁇ is therefore produced by using a solvent - preferably essentially aqueous -, optionally comprising solutes chosen from the following group: 10
- the temperature of the liquid media is also regulated by adding or removing calories, eg thermostatically controlled reactor with double wall for circulation of temperature-regulating fluid.
- the diffusion layers di, d ⁇ are obtained by setting the liquid in motion in each compartment C, / C ⁇ , this setting in motion taking place by stirring - preferably with using a rotor - in the first operating mode according to the invention and / or by circulation of said liquid according to the second operating mode of the method according to the invention.
- the stirring and / or circulation conditions are adjusted so that the non-turbulent diffusion layer or layers d, and d u have, in practice, thicknesses of at least 100 ⁇ m.
- auxiliary means for assisting the transmembrane migration preferably consisting of an ionic and / or electrical force gradient, on either side of the membrane, and more preferably still by pH gradients (protomotor force).
- the present invention relates to a dialysis device assisted by enzymatic pumping of at least one solute S characterized in that it essentially comprises:
- At least one container of a liquid medium At least one container of a liquid medium; "At least one porous membrane of thickness em, bathing or capable of bathing in the liquid medium, to at least partially delimit a liquid compartment C, intended to be depleted in solute S and at least partially a liquid compartment C
- At least one porous membrane of thickness em, bathing or capable of bathing in the liquid medium to at least partially delimit a liquid compartment C, intended to be depleted in solute S and at least partially a liquid compartment C
- C At least partially a liquid compartment C
- At least one enzyme E ⁇ capable of catalyzing, in C ,,, the reaction of transformation of S into solute-product S ⁇ II primary, E ⁇ being carried by the membrane on and / or in its face opposite C ⁇ ,
- Advantageously S ⁇ I1 and the membrane are entities of opposite electrical charges, the membrane (s), being charged, on at least one of its faces, preferably on Fskycarrying E ⁇ and more. preferably still on both.
- each membrane is electrically charged, on at least one of its faces, preferably on that adjacent to the face carrying the enzyme E p and more preferably still on both. 12
- this enzymatic membrane is a porous matrix, in and / or on the two faces F ⁇ , F, from which are included and immobilized the enzymes E ⁇ E p respectively, this matrix being formed by at least one macromolecular compound, preferably chosen from proteins, polysaccharides, synthetic (co) polymers and their mixtures and / or alloys, etc., these compounds being chosen for their porosity, thickness, zeta potential (charges) and ease grafting of E ⁇ / E p ; cellulose and its derivatives (eg cellulose acetate, regenerated cellulose) as well as (co) polyamides being particularly preferred.
- the enzymatic membrane is in the form of a monolayer or multilayer film, preferably substantially planar, once mounted in the device.
- the enzymatic membrane constitutes all or part of the wall of at least one tube, the lumen of which forms one of the compartments C,.
- pairs of enzymes that can be used in the process and the device according to the invention.
- these pairs E ⁇ / E p are mainly chosen from pairs of enzymes allowing the addition / removal of a charged chemical group on a metabolite, preferably from pairs of phosphorylation enzymes. / dephosphorylation, and more preferably still among kinases / phosphatases.
- - fig. 1 represents a simplified diagram of the first embodiment of the dialysis device assisted by enzymatic pumping, in accordance with the invention (discontinuous mode);
- FIG. 2 is a simplified diagram illustrating the second embodiment of the device according to the invention (continuous mode); 13
- - fig. 3 is a symbolic representation of the enzymatic membrane separating the two compartments C, and C fatigueof the device of FIG. 1 or 2, said representation corresponding to an embodiment of the dialysis process for a solute S, from compartment C, to compartment C ⁇ :
- - fig. 4 is a symbolic representation of the same nature as FIG. 2, with the difference that it relates to a 1st variant implementation of the dialysis process of the solute S from compartment Ci to compartment C ⁇ :
- FIG. 6 is a simplified view in right cross section along the line VI-VI of FIG. 2;
- - fig. 6 bis is an enlarged view of one of the elements of the tubular membrane seen in section in FIG. 6;
- - fig. 7 represents a graph of the concentrations in S ⁇ D ), S ⁇ concerned), Scj ( 0 ), S ⁇ ( # ) in Ci, C ⁇ , as a function of time t in min in the test carried out according to the topography of FIG. 3
- - fig. 8 shows a graph of the concentrations SK), S ⁇ c ,,), S ⁇ i ( 0 ), S ⁇ (# ), in mM, as a function of time t in min, in the test carried out according to the topography of FIG. 4;
- Fig. 9 represents a graph of the experimental concentrations Si (), S ⁇ ( B ), S ⁇ o ), Sont.) And theoretical S ⁇ th (curve a) in mM as a function of time t in min, in the test carried out according to the topography of fig. 5.
- the device for separating and concentrating at least one solute S to be dialyzed is designated in FIG. 1 by the general reference 1.
- This device or reactor 1 is constituted by a tank 2 14
- thermostatically controlled having a double wall, provided for the circulation of a thermoregulating fluid, between the inlet 2 d and the outlet 2 2 .
- This tank 2 has, for example, a generally substantially hollow cylindrical shape and can be produced from any suitable material, metallic, plastic (polymer e.g. of the polymethacrylate type).
- This tank 2 contains a liquid medium not referenced in the drawing and is also equipped with stirring means 3 symbolically represented and which are advantageously constituted by a rotor, which can be, for example, a magnetic bar operating with a magnetic stirrer, or even a conventional stirring propeller.
- stirring means 3 symbolically represented and which are advantageously constituted by a rotor, which can be, for example, a magnetic bar operating with a magnetic stirrer, or even a conventional stirring propeller.
- a tubular body 4 also containing liquid medium, partially bathes in the liquid medium contained in the tank 2.
- This tubular body 4 advantageously has a circular cross section.
- the submerged lower end of this tubular body 4 is closed by an enzymatic membrane 5 inserted between two annular peripheral seals 6, made - for example - of paraffinic plastic.
- the membrane 5 is secured to the tubular body 4 via a lip 7 or an annular rim formed at the free immersed end of said tubular body.
- the fixing means used are for example screws and nuts 8, e.g. Teflon.
- the tubular body 4 is equipped with stirring means 9, of the paddle type agitator.
- the liquid levels in the tank 2 (1st container) and in the tubular body 4 (2nd container) are adjusted so that they are identical.
- This membrane 5 also separates said compartment C, from compartment C ⁇ constituted by the tank 2 filled with liquid medium.
- the membrane 5 is made of natural polymer, modified or not, or of synthetic polymer. In this case, it is a polyamide membrane sold by Pall Europe limited, Portsmouth England under the reference Pall NAZ, in the form of nonwoven material, having a thickness of 100 ⁇ m eg
- the porosity of this membrane is defined by the cutoff threshold, the latter being naturally chosen as a function of the size of the molecules which it is desired to migrate through the membrane to overconcentrate them in a compartment. Expressed in maximum molecular weight for molecules 15
- this cut-off threshold is advantageously between 500 and 10 000 D, depending on the size of the molecules that one wants to over-concentrate.
- this membrane can also be made of regenerated cellulose and is in the form of a nonwoven film of thickness between
- Covalent grafting can be carried out according to conventional techniques.
- the examples which follow give an illustration of the enzymatic grafting.
- the second embodiment of the device according to the invention is shown in FIG. 2, on which it is designated by the general reference 10.
- This device 10 for dialysis of Ci- »C ⁇ of a solute S is capable of operating in a continuous mode.
- This device 10 comprises a thermostatically controlled tank 11 of the same type as that (2) described in the first embodiment of FIG. 1.
- 11 2 respectively designate the inlet and the outlet of the circulation circuit of a thermoregulatory fluid in the jacket of the tank 11.
- This tank 11 contains the liquid medium initially containing the solute S and constituting the liquid compartment C ⁇ .
- Means 12 of mechanical agitation are provided within this liquid medium forming C ,,.
- These stirring means 12 are of the same type as those described for the first embodiment shown in FIG. 1 and designated by the reference 9 in this figure.
- the enzymatic membrane consists of a plurality of tubes 13 with porous walls and grouped together to form a bundle 14, part of which is immersed in the liquid medium of the tank.
- the lights of the tubes 13 constitute as many compartments C, liquid, involved in the method according to the invention.
- the section in fig. 6 shows the bundle 14 of tubular enzymatic membranes 13.
- This bundle 14 has a curved U-shaped part, the base of which dips into the liquid compartment C ⁇ defined by the tank 11.
- This tubular bundle 14 is intended to allow the circulation of liquid medium to be depleted in solute S by active transmembrane migration .
- the bundle 14 is equipped with circulating means 15 constituted, for example, by a pump.
- Fig. 6 bis is a right cross-sectional view of a tubular enzymatic membrane 13 constituting the bundle 14 and delimiting through its wall, on the one hand, an internal compartment C (tube lumen), and on the other hand on the other hand, with regard to the submerged part of the bundle 14, an external compartment C ⁇ , defined by the tank 11.
- the wall of the tube 13 comprises on each of these internal and external faces an enzyme E ⁇ and E p respectively, constituting a pair of reversible enzymes.
- the methods of fixing and immobilizing the enzymes are the same as those described above.
- the constituent materials of these tubular membranes are also of the same nature as those mentioned for the membrane 5 of FIG. 1. In practice, this will, for example, be regenerated cellulose of a porous nature, having a cut-off threshold which may vary from 500 to 10,000 D.
- the latter also shows the internal diameter D of the hollow fiber 13, as well as the thickness em of the membrane wall charged with enzymes E ⁇ / E p .
- the sum of the volumes of compartments C, immersed in C , is less than the volume V ⁇ of compartment C ⁇ .
- the VV ratio is as low as possible.
- the tubular membranes 13 can be electrically charged in positive or in negative, so as to avoid the parasitic diffusion of Sound in Ci.
- This second embodiment of the device according to the invention is adapted to the second continuous mode of implementation of the dialysis process.
- the speed of circulation of the liquid medium in the compartments C is adapted to the total surface of the exchange zone in the submerged part, 17
- the symbolic representation of fig. 3 shows the membrane 5 carrying in its face F ⁇ opposite C ⁇ the enzyme E ⁇ .
- This membrane has a thickness em. It is adjoined by its face F ⁇ with a diffusion layer d ⁇ and by its face Fi opposite Ci with another diffusion layer di, of thickness edi.
- the reference S includes the index I or II separated by a comma from the parameter t corresponding to time.
- the reference S includes by exposing the letters d and b (b for "bulk” in English) respectively.
- the second exponent of the reference S corresponds to the negative (-) or neutral (o) charge of the solute.
- Fig. 4 schematically represents the topography specific to the first variant of implementation of the method according to the invention.
- the F ⁇ and Fi faces of the membrane respectively carry the reversible enzymes E ⁇ / Ep.
- the solute Si crosses the membrane to pass from Ci into C ⁇ and to be partly metabolized in the diffusion layer d ⁇ adjoining the face F ⁇ of C ⁇ , in solute Son, by the enzyme E ⁇ i.
- S ⁇ and Son diffuse in C ⁇ , similarly that Self diffuses in Ci.
- the membrane is preferably electrically charged with the same sign as Sound, in this case negatively, so as to limit the diffusion of Sound in Ci.
- Fig. 5 corresponds to the second variant of implementation of the method according to the invention.
- the compartment C ⁇ comprises an enzyme E ⁇ capable of metabolizing Sound to S ⁇ , this transformation taking place preferably in the part of C ⁇ different from the non-turbulent diffusion layer d ⁇ . 18
- the dialysis membranes used are membranes of the Pall NAZ type sold by the company PALL EUROP LIMITED. These are polyamide membranes with a thickness equal to 100 ⁇ m of active transfer area (Aw) of 12% and referenced under the number 09025. We also use regenerated cellulose dialysis membranes, with a thickness of 40 ⁇ m, sold under the name spectra / Por. 3500 MWCO - ref 132723 by spectrum. These dialysis membranes are those that do not carry enzymes.
- the enzyme E ⁇ glycerolkinase - GK - (EC2.7.1.30) from the species cellulomonas (52 units. Mg -1 , ref.g. 6142).
- E p E ⁇ alkaline phosphatase -PA- (EC3.1.3.1.) Extracted from bovine intestinal mucosa (1200 Units.mg " 1 , ref. P 6672).
- the enzymes E ⁇ , E p and E ⁇ defined above are marketed by the company SIGMA.
- the immobilization of the enzymes on the membrane operates as follows:
- the membranes are in the form of discs 5 cm in diameter which are activated using a solution of sulfuric acid in methanol under reflux for 6 hours. They are then subjected to the action of a 2% V / V glutaraldehyde solution, as described in the article by Michalon, P., Couturier, R., Hacques, MF., Favre-Bonvin, G, Ville , A. & Marion, C. (1990) Biochem. Biophys. Res. Common, 167, 9-15. 19
- the temperature of the liquid medium is thermostatically controlled by the tank at 25 °. C. The other operating conditions vary according to the tests carried out.
- liquid media C [ / C ⁇ contain 0.1 M borate buffer in an amount such that the pH is of the order of 9 as well as ATP Mg Cl 2 - 7 mM.
- E ⁇ GK.
- the enzymatic reactions used in the examples are as follows:
- the glucose concentrations are determined from samples taken in the compartments Ci and C ⁇ , using a sensor formed by an enzymatic electrode composed by an amperometric platinum probe associated with a membrane nylon loaded with glucose oxidase, this probe being coupled to a PRGE type polarograph from the company RADIOMETER (VILLEURBANNE, FRANCE), (THEVENOT et al), 1979.
- This biosensor allows glucose concentration determinations according to the following reaction: glucose oxidase D-glucose + O 2 ⁇ ac ide gluconic + H 2 O 2
- the anode current thus obtained is proportional to the H 2 O 2 concentrations, which are themselves proportional to the glucose concentrations.
- the thickness em of the dialysis membrane loaded with GK opposite C ⁇ is 240 ⁇ m.
- the stirring conditions of this test are respectively 180 revolutions / min and 100 revolutions / min in Ci and C ⁇ . 20
- the NAZ discs loaded with GK are immersed in a ml of 0.1 M borate buffer pH 8.5 containing 7 mM ATP / MgCl 2 in the presence of a saturated concentration of glucose, i.e. 0.2 M, at 25 ° C. Samples are taken every 5 min for 20 min. In these samples, the G-6-P "concentration is measured, so as to determine the GK activity.
- NAZ disks loaded with PA are immersed in 5 ml of 0.1 M borate buffer, pH 8.5 in the presence of 33 mM G-6-P "(saturation concentration). Samples are sampled every 5 min for 20 min and the glucose concentration is measured in these to deduce the PA activity.
- the liquid medium of Ci, C ⁇ consists of 0.1 M phosphate buffer containing 7 mM ATP / MgCl 2 , at pH 8.5 and at 25 ° C.
- the stirring conditions are 180 revolutions / min and 100 revolutions / min in Ci and C ⁇ respectively.
- FIG. 8 clearly shows that the G-6-P " produced in C ⁇ (Son) does not pollute C,; S o i is constant and is equal to 0. Furthermore, the concentration Si of glucose in Ci decreases rapidly in 500 min. S ⁇ glucose concentration in C ⁇ decreases less rapidly than Si while Son increases regularly.
- Fig. 9 shows the results obtained and it appears that no pollution of compartment I by the G-6-P "produced in C ⁇ occurs.
- the concentration S o n remains constantly zero in C ⁇ .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Vascular Medicine (AREA)
- Sustainable Development (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- External Artificial Organs (AREA)
Abstract
Description
PROCEDE D'ELIMINATION ACTIVE ET SELECTIVE DE PETITES MOLECULES PAR POMPAGE ENZYMATIQUE : DIALYSE ACTIVEACTIVE AND SELECTIVE REMOVAL OF SMALL MOLECULES BY ENZYMATIC PUMPING: ACTIVE DIALYSIS
DOMAINE TECHNIQUE : Le domaine de la présente invention est celui de la séparation et de l'élimination / épuration de petites molécules (solutés) en phase liquide, par passage au travers d'une membrane poreuse bioactive. Cela vise la dépollution d'un compartiment liquide donné par élimination de solutés indésirables ou, de manière plus générale, l'isolement de certains solutés non nécessairement polluants mais pouvant être dotés d'une haute valeur ajoutée. Ces techniques de transport de solutés ioniques ou non par diffusion au travers d'une membrane, dont le rôle est d'empêcher le transport convectif du solvant, sont communément désignées par le terme dialyse.TECHNICAL FIELD: The field of the present invention is that of the separation and elimination / purification of small molecules (solutes) in the liquid phase, by passage through a porous bioactive membrane. This is aimed at the depollution of a given liquid compartment by elimination of undesirable solutes or, more generally, the isolation of certain solutes which are not necessarily polluting but which may have high added value. These techniques for transporting ionic solutes or not by diffusion through a membrane, the role of which is to prevent convective transport of the solvent, are commonly known by the term dialysis.
L'invention concerne donc un procédé de dialyse active et sélective, assistée par pompage enzymatique d'au moins un soluté S au travers d'au moins une membrane poreuse séparant au moins en partie deux compartiments liquides C, et Cπ, le transfert s' opérant de C, que l'on appauvrit en S vers C,, que l'on enrichit conséquemment en S.The invention therefore relates to a method of active and selective dialysis, assisted by enzymatic pumping of at least one solute S through at least one porous membrane separating at least partially two liquid compartments C, and C π , the transfer s operant of C, which one impoverishes in S towards C ,, which one consequently enriches in S.
L'invention vise également un dispositif de dialyse assistée par pompage enzymatique, utile notamment pour la mise en oeuvre du procédé sus-visé.The invention also relates to a dialysis device assisted by enzymatic pumping, useful in particular for the implementation of the above-mentioned process.
TECHNIQUE ANTERIEURE :PRIOR TECHNIQUE:
La dialyse par diffusion transmembranaire passive est connue depuis longtemps. Elle a fait l'objet d'applications ponctuelles nombreuses dans l'industrie chimique et dans les domaines agroalimentaire et pharmaceutique. Il s'agit essentiellement d'une opération lente qui est conditionnée par l'existence d'un gradient de concentration de part et d'autre de la membrane pour le ou les solutés à séparer et/ou à éliminer. La dialyse s'est donc avérée relativement coûteuse au plan industriel. C'est ainsi que des procédés plus radicaux, fondés sur des forces motrices externes (mécaniques ou électriques), ont été beaucoup plus étudiés et exploités, malgré leur coût énergétique plus élevé. De fait, la dialyse industrielle ne devient compétitive que lorsque ces procédés consommateurs d'énergie sont inopérants, lorsqu'ils risquent d'endommager le soluté à isoler ou encore lorsque la lenteur de l'opération de dialyse ne constitue pas un handicap. Ces trois conditions s'appliquent à une technique qui n'est pas spécifiquement industrielle, mais qui à l'heure actuelle constitue l'application la plus importante de la dialyse : l' hémodialyse. L'hémodialyse est une technique médicale destinée à des sujets atteints d'une insuffisance rénale partielle ou totale. Elle consiste en un traitement extracorporel du sang, assurant les mêmes fonctions que le rein, grâce à un procédé membranaire fondé à la fois sur la dialyse et Pultrafiltration. Solution moins élégante que la transplantation d'organes, elle est indispensable étant donné la disproportion entre le nombre des donneurs potentiels et celui des demandeurs. Les petites molécules que l'on cherche à éliminer du sang en hémodialyse sont l'urée, l'acide urique, la créatinine et les autres déchets métaboliques de faible poids moléculaire. Cette élimination doit se faire sélectivement en permettant au sang traité de conserver les macromolécules et les métabolites indispensables à ces fonctions et en préservant ses bilans électrolytiques et aqueux.Passive transmembrane diffusion dialysis has been known for a long time. It has been the subject of numerous ad hoc applications in the chemical industry and in the food and pharmaceutical fields. It is essentially a slow operation which is conditioned by the existence of a concentration gradient on either side of the membrane for the solute (s) to be separated and / or eliminated. Dialysis has therefore proven to be relatively expensive on an industrial scale. This is how more radical processes, based on external driving forces (mechanical or electrical), have been much more studied and exploited, despite their higher energy cost. In fact, industrial dialysis only becomes competitive when these energy-consuming processes are ineffective, when they risk damaging the solute to be isolated or when the slowness of the dialysis operation does not constitute a handicap. These three conditions apply to a technique which is not specifically industrial, but which at present constitutes the most important application of dialysis: hemodialysis. Hemodialysis is a medical technique intended for subjects suffering from partial or total renal insufficiency. It consists of an extracorporeal treatment of the blood, ensuring the same functions as the kidney, thanks to a membrane process based on both dialysis and ultrafiltration. A less elegant solution than organ transplantation, it is essential given the disproportion between the number of potential donors and that of applicants. The small molecules that we seek to eliminate from blood on hemodialysis are urea, uric acid, creatinine and other metabolic wastes of low molecular weight. This elimination must be done selectively by allowing the treated blood to conserve the macromolecules and metabolites essential to these functions and by preserving its electrolytic and aqueous balance sheets.
Outre l'hémodialyse, on connaît également l'hémofiltration comme méthode d'élimination de certains solutés indésirables du sang. Le principe de l'hémofiltration consiste à utiliser la filtration comme moteur des échanges de solutés. L'hémofiltration permet une bonne épuration des moyennes molécules.In addition to hemodialysis, hemofiltration is also known as a method of removing certain undesirable solutes from the blood. The principle of hemofiltration consists in using filtration as a motor for the exchange of solutes. Hemofiltration allows good purification of medium molecules.
D'une façon générale, dans ces deux procédés, le sang est épuré de façon passive (hémodialyse) ou en créant une légère différence de pression entre le sang circulant dans la lumière de fibres creuses et un liquide appelé dialysat circulant à l'extérieur des fibres (hémofiltration). Dans les deux cas, la diffusion passive ou provoquée ne permet pas de différencier entre elles les petites molécules contenues dans le sang, selon qu'elles soient nocives et donc à éliminer ou indispensables et donc à conserver.Generally, in these two processes, the blood is purified passively (hemodialysis) or by creating a slight pressure difference between the blood circulating in the lumen of hollow fibers and a liquid called dialysate circulating outside the fibers (hemofiltration). In both cases, passive or induced diffusion does not differentiate between them the small molecules contained in the blood, depending on whether they are harmful and therefore to be eliminated or essential and therefore to be preserved.
L'élimination sélective de certaines petites molécules n'est donc pas possible par les techniques connues d'hémodialyse ou d'hémofiltration. Pour pallier cela, il serait intéressant de disposer d'une nouvelle technique permettant d'éliminer rapidement et sélectivement une petite molécule donnée.The selective elimination of certain small molecules is therefore not possible by known techniques of hemodialysis or hemofiltration. To overcome this, it would be interesting to have a new technique to quickly and selectively eliminate a given small molecule.
De surcroît, on sait que pour que les techniques de dialyse soient efficaces, il est impératif qu'il existe un gradient de concentration de part et d'autre de la membrane, le soluté concerné circulant du compartiment le plus concentré vers le compartiment le moins concentré en soluté. Cela suppose la mise en oeuvre de grands volumes de dialysat pour diminuer les concentrations à l'extérieur du compartiment à dépolluer. Outre les difficultés de manipulation et d'encombrement qu'ils entraînent, ces grands volumes de dialysat ont également pour inconvénient d'entraîner la fuite de molécules ou de solutés sanguins indispensables. EXPOSE SUCCINCT DE L'INVENTION :Furthermore, it is known that for dialysis techniques to be effective, it is imperative that there is a concentration gradient on either side of the membrane, the solute concerned circulating from the most concentrated compartment to the least compartment. concentrated in solute. This requires the use of large volumes of dialysate to reduce the concentrations outside the compartment to be decontaminated. In addition to the handling and bulk difficulties which they entail, these large volumes of dialysate also have the drawback of causing the leakage of molecules or of essential blood solutes. SHORT STATEMENT OF THE INVENTION:
Dans un tel état de la technique, l'un des objectifs essentiel de la présente invention est d'améliorer les techniques connues de séparation ou d'élimination de certains solutés par diffusion transmembranaire, en fournissant un procédé de dialyse forcée permettant d'abaisser de façon conséquente rapide et sélective le niveau de concentration d'un soluté dans un compartiment liquide donné, en le transférant au travers d'une membrane dans un autre compartiment liquide, quel que soit le niveau de concentration du soluté considéré dans ce dernier compartiment, c'est-à-dire même en l'absence d'un gradient de concentration favorable à un flux de diffusion du compartiment le plus concentré vers le compartiment le moins concentré.In such a state of the art, one of the essential objectives of the present invention is to improve the known techniques of separation or elimination of certain solutes by transmembrane diffusion, by providing a method of forced dialysis making it possible to lower consequently quickly and selectively the level of concentration of a solute in a given liquid compartment, by transferring it through a membrane into another liquid compartment, whatever the level of concentration of the solute considered in this latter compartment, c that is to say even in the absence of a concentration gradient favorable to a diffusion flow from the most concentrated compartment to the least concentrated compartment.
Un autre objectif essentiel de l'invention est de fournir un procédé de dialyse forcée permettant d'extraire, par exemple à des fins de dépollution, de purification ou d'isolement, un soluté donné en mettant en oeuvre une diffusion transmembranaire ayant une cinétique significativement supérieure à celle d'un processus classique de diffusion transmembranaire passive.Another essential objective of the invention is to provide a method of forced dialysis making it possible to extract, for example for the purpose of depollution, purification or isolation, a given solute by implementing a transmembrane diffusion having significantly kinetic superior to that of a conventional passive transmembrane diffusion process.
Un autre objectif essentiel de la présente invention est de fournir un procédé de dialyse forcée différentielle et donc sélective pour un ou plusieurs solutés.Another essential objective of the present invention is to provide a method of differential and therefore selective forced dialysis for one or more solutes.
Un autre objectif essentiel de la présente invention est de fournir un procédé de dialyse simple, rapide et économique. Un autre objectif essentiel de la présente invention est de fournir un procédé de dialyse sélective et rapide qui permette de s'affranchir du recours à de grandes quantités de dialysats jusqu'alors utiles pour générer des gradients de concentration nécessaires à la diffusion passive.Another essential objective of the present invention is to provide a simple, rapid and economical dialysis process. Another essential objective of the present invention is to provide a selective and rapid dialysis process which makes it possible to dispense with the use of large quantities of dialysates hitherto useful for generating concentration gradients necessary for passive diffusion.
Un autre objectif essentiel de la présente invention est de fournir un procédé de dialyse simple, sélectif, rapide, économique et applicable notamment en hémodialyse de manière performante.Another essential objective of the present invention is to provide a simple, selective, rapid, economical dialysis process which can be applied in hemodialysis in an efficient manner.
Un autre objectif essentiel de la présente invention est de fournir un dispositif de dialyse propre à permettre notamment la mise en oeuvre du procédé sus- visé. Un autre objectif essentiel de l'invention est de fournir un dispositif de dialyse simple, économique, sélectif et rapide.Another essential objective of the present invention is to provide a dialysis device capable of allowing in particular the implementation of the abovementioned process. Another essential objective of the invention is to provide a simple, economical, selective and rapid dialysis device.
S'étant fixé ces objectifs, les inventeurs ont eu le mérite de mettre en évidence, après de longues et laborieuses recherches et expérimentations, qu'il était possible d'atteindre ces objectifs en stimulant et en optimisant le phénomène de diffusion passive, par mise en oeuvre d'un système de pompage enzymatique auxiliaire. Ce mécanisme auxiliaire original, découvert par les inventeurs, repose sur l'intervention d'au moins une enzyme spécifique du soluté considéré et disposée sur la face d'une membrane poreuse opposée à celle qui est en regard du compartiment liquide que l'on cherche à appauvrir en soluté par diffusion transmembranaire. Un tel système enzymatique peut comprendre au moins un couple d'enzymes inverses, l'une des enzymes du couple étant fixée d'un côté de la membrane, tandis que l'autre enzyme est immobilisée de l'autre côté de cette membrane, ces enzymes étant, en outre, éventuellement contenues dans le milieu liquide des compartiments, à l'exclusion de la membrane enzymatique poreuse de diffusion. Ce système se comporte comme une pompe qui génère et maintient un écart de concentration en soluté(s) à transférer entre les deux compartiments.Having set these objectives, the inventors had the merit of highlighting, after long and laborious research and experiments, that it was possible to achieve these objectives by stimulating and optimizing the phenomenon of passive diffusion, by putting using an auxiliary enzymatic pumping system. This original auxiliary mechanism, discovered by the inventors, is based on the intervention of at least one enzyme specific to the solute considered and placed on the face of a porous membrane opposite that which is opposite the liquid compartment which it is sought to deplete in solute by transmembrane diffusion. Such an enzymatic system can comprise at least one pair of reverse enzymes, one of the enzymes of the pair being fixed on one side of the membrane, while the other enzyme is immobilized on the other side of this membrane, these enzymes being, in addition, possibly contained in the liquid medium of the compartments, with the exclusion of the porous enzymatic diffusion membrane. This system behaves like a pump which generates and maintains a difference in concentration of solute (s) to be transferred between the two compartments.
Il en résulte que la présente invention concerne tout d'abord un procédé de dialyse assistée par pompage enzymatique d'au moins un soluté S au travers d'au moins une membrane poreuse séparant au moins en partie deux compartiments liquides C, et C,,, (S étant référencé S, dans C, et S,, dans C,,), cette dialyse s' opérant du compartiment liquide C, que l'on vise à appauvrir en S, vers le compartiment liquide Cπ destiné conséquemment à s'enrichir en S, caractérisé en ce qu'il consiste essentiellement et successivement ou non :As a result, the present invention relates first of all to a dialysis process assisted by enzymatic pumping of at least one solute S through at least one porous membrane separating at least partially two liquid compartments C, and C ,, , (S being referenced S, in C, and S ,, in C ,,), this dialysis taking place from the liquid compartment C, which we aim to deplete in S, towards the liquid compartment C π intended consequently for s '' enrich in S, characterized in that it consists essentially and successively or not:
• à mettre en oeuvre au moins une membrane poreuse comprenant sur et/ou dans sa face Fπ en regard de Cπ au moins une enzyme Eα apte à catalyser la réaction de transformation du soluté SU en soluté- produit primaire Son ;• to use at least one porous membrane comprising on and / or in its face F π opposite Cπ at least one enzyme E α capable of catalyzing the reaction of transformation of the solute SU into solute- primary product Sound;
• à mettre en mouvement au moins le liquide de Cπ (dialysat), et de préférence également celui de C,, en prévoyant au moins une couche de diffusion dπ non-turbulente, attenante à la face Fπ de la membrane porteuse de Eα et en regard de Cπ, et en réglant l'épaisseur edπ de cette couche de diffusion dπ de manière que• to set in motion at least the liquid of C π (dialysate), and preferably also that of C ,, by providing at least one non-turbulent d π diffusion layer, adjoining the face F π of the membrane carrying E α and opposite C π , and by adjusting the thickness ed π of this diffusion layer d π so that
— em < ed ι„ < 10. em, d ,e pré ,f<*é,rence — em < ed„ < 3.em ;- e m <ed ι „<10. em, d, e pré, f <* é, rence - em <ed„ <3.em;
10 2 em étant l'épaisseur de la membrane ;10 2 em being the thickness of the membrane;
• et à faire en sorte que les conditions opératoires soient telles qu'interviennent :• and to ensure that the operating conditions are such that:
* la transformation enzymatique par Eα de S,, en SαII,* the enzymatic transformation by E α of S ,, into S αII ,
* et corrélativement la diffusion de S,, au travers de la membrane du compartiment Cj vers le compartiment C , notamment sous l'effet d'un pompage enzymatique, induit par la réaction* and correlatively the diffusion of S ,, through the membrane of compartment C j towards compartment C, in particular under the effect of an enzymatic pumping, induced by the reaction
E αE α
S ^ SS ^ S
Le principe technique novateur qui gouverne le procédé conforme à l'invention, peut être assimilé à un mécanisme de pompage enzymatique permettant de transférer un soluté S dans un compartiment (I) liquide de départ, vers un compartiment (II) liquide d'arrivée, par transport actif au travers d'une membrane poreuse enzymatique. Le soluté S s'accumule ainsi et se concentre dans le compartiment d'arrivée, et ce même si la concentration du soluté dans ce dernier est supérieure à celle de S dans le compartiment de départ. Qui plus est, le pompage enzymatique selon l'invention a pour effet de maintenir un écart de concentration ΔS = [Sπ]-[S,] > 0.The innovative technical principle which governs the process according to the invention can be assimilated to an enzymatic pumping mechanism making it possible to transfer a solute S in a compartment (I) starting liquid, to a compartment (II) arriving liquid, by active transport through an porous enzymatic membrane. The solute S thus accumulates and concentrates in the arrival compartment, even if the concentration of the solute in the latter is higher than that of S in the departure compartment. What is more, the enzymatic pumping according to the invention has the effect of maintaining a concentration difference ΔS = [S π ] - [S,]> 0.
Un tel procédé de pompage enzymatique est particulièrement avantageux puisqu'il permet une élimination rapide et sélective d'un ou plusieurs solutés d'un compartiment liquide Ci, par exemple le sang (hémodialyse), et ce sans mise en oeuvre de grands volumes de dialysat Cπ sans consommation exagérée d'énergie. Cette pompe enzymatique ne nécessite essentiellement que de l'énergie chimique, qui peut être apportée, par exemple, par des molécules à liaison riche en énergie, telles que l'adénosine triphosphate (ATP).Such an enzymatic pumping process is particularly advantageous since it allows rapid and selective elimination of one or more solutes from a liquid compartment Ci, for example blood (hemodialysis), without using large volumes of dialysate. Cπ without excessive energy consumption. This enzymatic pump essentially only requires chemical energy, which can be provided, for example, by molecules with an energy-rich bond, such as adenosine triphosphate (ATP).
Il est à noter que le gain cinétique procuré par l'invention, reste compatible avec le seuil de durée en deçà duquel on génère un stress sanguin dans l'application hémodialyse.It should be noted that the kinetic gain provided by the invention remains compatible with the duration threshold below which a blood stress is generated in the hemodialysis application.
Ceci est lié au fait que les couches de diffusion non-turbulentes propres au procédé selon l'invention, limitent quelque peu les vitesses de circulation du sang et du dialysat lors de l'hémodialyse. La mise au point du procédé selon l'invention trouve racine, notamment, dans la compréhension du phénomène de transport actif propre aux membranes biologiques. Cette nouvelle théorie scientifique sur les transports transmembranaires biologiques apporte du sang nouveau à l'état des connaissances scientifiques en la matière. Ce dernier peut se résumer en la théorie basée sur les pores et en la théorie fondée sur la transformation conformationnelle des protéines des membranes biologiques.This is linked to the fact that the non-turbulent diffusion layers specific to the method according to the invention somewhat limit the speeds of circulation of the blood and of the dialysate during hemodialysis. The development of the method according to the invention finds its root, in particular, in understanding the phenomenon of active transport specific to biological membranes. This new scientific theory on biological transmembrane transport brings new blood to the state of scientific knowledge on the subject. The latter can be summarized in the theory based on pores and in the theory based on the conformational transformation of proteins of biological membranes.
La démarche nouvelle et innovante selon l'invention a donc consisté, dans un premier temps, à comprendre et expliquer le phénomène biologique et, dans un deuxième temps, à le reproduire (mimétisme) en l'adaptant aux spécifications médicales ou industrielles de séparation/élimination concentration de composés chimiques, en particulier à des fins d'élimination et d'isolement de composés toxiques, ou à des fins de récupération de molécules à haute valeur ajoutée : chimique, pharmaceutique, cosmétique ou autres.The new and innovative approach according to the invention therefore consisted, firstly, of understanding and explaining the biological phenomenon and, secondly, of reproducing it (mimicry) by adapting it to medical or industrial separation specifications / elimination of chemical compounds, particularly for the purposes of elimination and isolation of toxic compounds, or for the recovery of molecules with high added value: chemical, pharmaceutical, cosmetic or others.
Conformément à une caractéristique préférée de l'invention, on sélectionne d'une part, l'enzyme Eαqui régit la production de Sα,, et, d'autre part, la membrane poreuse, de manière à ce que cette dernière soit imperméable à SαII et empêche ainsi, au moins partiellement, la diffusion de SαI, de Cπ vers C, ; SαII et la membrane étant ainsi, de préférence, des entités de charges électriques de même signe.In accordance with a preferred characteristic of the invention, the enzyme E α which governs the production of S α ,, is selected on the one hand and, on the other hand, the porous membrane, so that the latter is impermeable to S αII and thus prevents, at least partially, the diffusion of S αI , from C π to C ,; S αII and the membrane thus being preferably entities of electric charges of the same sign.
Le caractère électriquement chargé de SαII résulte de l'action de l'enzyme Eα sur le substrat neutre Sπ.The electrically charged nature of S αII results from the action of the enzyme E α on the neutral substrate S π .
La charge électrique des faces de la membrane poreuse peut être obtenue par exemple, en immobilisant, sur la membrane, les enzymes Eα et Ep et des polyaminoacides dont les pK confèrent à la membrane, pour un pH donné, des charges négatives ou positives. Ainsi, dans le cas où le polyaminoacide est e.g. la polylysine, alors la membrane est chargée positivement à pH 9, tandis qu'avec un polyaminoacide correspondant e.g. à un polyglutamate, la membrane est chargée négativement à pH 9.The electrical charge of the faces of the porous membrane can be obtained, for example, by immobilizing, on the membrane, the enzymes E α and E p and polyamino acids, the pK of which give the membrane, for a given pH, negative or positive charges. . Thus, in the case where the polyamino acid is eg polylysine, then the membrane is positively charged at pH 9, while with a polyamino acid corresponding eg to a polyglutamate, the membrane is negatively charged at pH 9.
Selon une alternative, on peut choisir des membranes dont le potentiel zêta au pH optimum est adapté à des conditions données du procédé de l'invention. En l'absence de moyens pour empêcher la pollution du compartiment liquide C, par le produit SαII de la réaction impliquant Sπ comme substrat et Eα comme enzyme ou pour compléter l'action de ces moyens, il est prévu une première variante au procédé selon l'invention dans laquelle :According to an alternative, membranes can be chosen whose zeta potential at the optimum pH is adapted to given conditions of the process of the invention. In the absence of means to prevent pollution of the liquid compartment C, by the product S αII of the reaction involving S π as a substrate and E α as an enzyme or to complete the action of these means, a first variant is provided for. process according to the invention in which:
• on met en oeuvre au moins une membrane poreuse comportant sur et/ou dans sa face F, en regard de C,, au moins une enzyme Ep apte à catalyser la réaction de transformation du soluté-produit primaire SαI issu de la diffusion au travers de la membrane de SαII de C„ vers C, en soluté-produit secondaire Sβ,,• at least one porous membrane is used, comprising on and / or in its face F, opposite C ,, at least one enzyme E p capable of catalyzing the reaction of transformation of the solute-primary product S αI resulting from the diffusion through the membrane of S αII from C „to C, in solute-secondary product S β ,,
Ep étant de préférence l'enzyme inverse de Eα de sorte que Spι = S,, « on prévoit une mise en mouvement des liquides de C, et C„ en ménageant une couche de diffusion d,, dπ non-turbulente connexe à chaque face F,, F,,, et en ajustant les épaisseurs ed, et edπ de ces couches de telle sorte que : * 0,1. em < ed./ edrj ≤ 10. em, * de préférence 0, 5. em < ed, / edπ < 3. em ; • on fixe des conditions opératoires propices à la transformation enzymatique par Ep de SαI en Spι, et, corrélativement, dans le cas où Spι = S,, la diffusion de Spι de C, vers Cπ, au travers de la membrane, sous l'effet, notamment, d'un pompage enzymatiqueEp preferably being the inverse enzyme of E α so that S pι = S ,, "provision is made for a movement of the liquids of C, and C„ by providing a diffusion layer d ,, d π connected non-turbulent on each face F ,, F ,,, and by adjusting the thicknesses ed, and ed π of these layers so that: * 0.1. em <ed./ ed rj ≤ 10. em, * preferably 0, 5. em <ed, / ed π <3. em; • operating conditions favorable to the enzymatic transformation by E p of S αI into S pι are fixed , and, correlatively, in the case where S pι = S ,, the diffusion of S pι from C, towards C π , through the membrane, under the effect, in particular, of an enzymatic pumping
E α s„ — S résultant induit par la réaction απ .E α s „- S resulting induced by the reaction απ .
On est donc ici en présence d'une membrane poreuse séparant C! et C„ et porteuse sur chacune de ses faces F, et Fπ d'enzymes, de préférence réversibles, Ep et Eα respectivement. La pompe enzymatique ainsi équipée de moyens enzymatiques suplémentaires, permet la retransformation des métabolites SαIrésultant du transfert des métabolites Sα„ de C,, vers C,. Le métabolite SαI retransformé en S, dans C, peut dès lors rejoindre le flux de transfert de S de C, vers C,, au travers de la membrane.So here we are in the presence of a porous membrane separating C ! and C „and carrying on each of its faces F, and F π enzymes, preferably reversible, E p and E α respectively. The enzymatic pump thus equipped with additional enzymatic means, allows the retransformation of the metabolites S αI resulting from the transfer of the metabolites S α „from C ,, to C ,. The metabolite S αI retransformed into S, in C, can therefore join the transfer flow of S from C, to C ,, through the membrane.
Conformément à l'invention, il pourrait être envisagé de fixer Ep sur un autre support que la face F, de la membrane. Ep pourrait ainsi être portée par une membrane annexe et/ou sur tout autre support solide dispersé ou non dans C, Selon une deuxième variante du procédé selon l'invention :According to the invention, it could be envisaged to fix E p on a support other than the face F, of the membrane. E p could thus be carried by an annex membrane and / or on any other solid support dispersed or not in C, according to a second variant of the method according to the invention:
• on fait intervenir dans Cπ, au moins une enzyme E apte à catalyser la réaction de transformation du soluté S^ en soluté S,,, • at least one enzyme E is used in C π capable of catalyzing the reaction for transforming the solute S ^ into the solute S ,,,
• et on fixe des conditions opératoires propices au déroulement de• and operational conditions favorable to the development of
Eδ E δ
S S cette transformation Dans cette deuxième variante, on élimine le métabolite SαII au fur et à mesure de sa formation, pour enrichir encore C,, en soluté S,,. Ce faisant, on accroît encore l'écart de concentration ΔS = [Sι,]-[S,]. Cela confirme si il en était besoin que le pompe enzymatique selon l'invention fonctionne en générant ce ΔS et en le maintenant.SS this transformation In this second variant, the metabolite S αII is eliminated as it is formed, to further enrich C ,, in solute S ,,. In doing so, the concentration difference ΔS = [S ι ,] - [S,] is further increased. This confirms whether it was necessary for the enzymatic pump according to the invention to operate by generating this ΔS and maintaining it.
Il ressort de la description ci-dessus qu'il importe conformément à l'invention de prévoir une couche de diffusion di, dπ non-turbulente attenante à chaque face Fi, Fπ de la ou des membranes, surtout dès lors que la face considérée est porteuse d'une enzyme constitutive de la pompe enzymatique.It emerges from the above description that it is important according to the invention to provide a non-turbulent diffusion layer di, dπ adjoining each face Fi, Fπ of the membrane or membranes, especially when the face considered is carrying an enzyme constituting the enzyme pump.
Les différences entre les taux d'apparition et de disparition du soluté S dans les compartiments C,, C„, de part et d'autre de la membrane, dépend notamment du bon fonctionnement de la pompe enzymatique et donc en partie des épaisseurs des couches de diffusion non turbulentes, mais également pour une autre part des volumes des compartiments C, et C,,. C'est ainsi que le volume Vπ de Cπ est de préférence supérieur au volume V, de C,. Avantageusement le ratio Vπ/Vi est le plus grand possible de façon à faciliter la cinétique du transport.The differences between the rates of appearance and disappearance of the solute S in the compartments C ,, C „, on either side of the membrane, depends in particular on the proper functioning of the enzymatic pump and therefore in part on the thicknesses of the layers non-turbulent diffusion, but also for another part of the volumes of compartments C, and C ,,. This is how the volume V π of C π is preferably greater than the volume V, of C ,. Advantageously, the ratio Vπ / Vi is as large as possible so as to facilitate the kinetics of the transport.
E S, α ES, α
Pour que les transformations enzymatiques *• S au etSo that the enzymatic transformations * • S au and
EP E P
Sa l SP' interviennent au voisinage de chacune des faces Fi, Fπ de la membrane, il est non seulement important de prévoir les couches de diffusion di et dπ évoquées ci-dessus, mais également de mettre en place des conditions opératoires optimales, notamment de pH et de température, qui seront détaillés infra. S'agissant des couches de diffusion, le réglage des conditions d'agitation, donc des épaisseurs Edi et Edπ des couches de de diffusion non turbulentes di et dπ, peut être effectué en s'inspirant de l'article de BARDELETTI, G, B. MAISTERRENA and P. R. COULET, 1985 "Boundary loyer effect on product flux-splitting in an immobilized ensyme membrane System" ; J. Membrane Sci. 24 ; 185-296. Selon une caractéristique préférée de l'invention, Edi, Edπ sont comprises entre 50 et 500 micromètres, selon les conditions hydrodynamiques imposées. La deuxième variante correspond au mode de mise en oeuvre préféré de l'invention, qui cumule les avantages d'un système de pompage enzymatique comprenant deux enzymes réversibles fixées, respectivement, l'une et l'autre sur les faces opposées d'une membrane poreuse de diffusion et une troisième enzyme active dans le compartiment C„ destinée à s'enrichir en soluté S diffusant au travers de la membrane. Cette troisième enzyme Eδ est, de préférence, (tout comme Ep) l'enzyme inverse de l'enzyme Eαde C,,. Sa l S P 'occur in the vicinity of each of the faces Fi, F π of the membrane, it is not only important to provide the diffusion layers di and d π mentioned above, but also to set up optimal operating conditions , in particular pH and temperature, which will be detailed below. With regard to the diffusion layers, the adjustment of the stirring conditions, therefore of the thicknesses Edi and Ed π of the non-turbulent diffusion layers di and dπ, can be carried out on the basis of the article by BARDELETTI, G, B. MAISTERRENA and PR COULET, 1985 "Boundary rent effect on product flux-splitting in an immobilized ensyme membrane System"; J. Sci membrane. 24; 185-296. According to a preferred characteristic of the invention, Edi, Ed π are between 50 and 500 micrometers, depending on the hydrodynamic conditions imposed. The second variant corresponds to the preferred embodiment of the invention, which combines the advantages of an enzymatic pumping system comprising two reversible enzymes fixed, respectively, one and the other on the opposite faces of a membrane porous diffusion and a third active enzyme in compartment C „intended to enrich in solute S diffusing through the membrane. This third enzyme E δ is preferably (just like E p ) the inverse enzyme of the enzyme E α of C ,,.
L'enzyme Eδ est avantageusement contenue dans Cπ sur un autre support que la face Fπ de la membrane. Eδ peut ainsi être, par exemple, fixée sur une membrane annexe ou tout autre support convenable baignant dans C,, ou bien encore être dispersée dans Cπ.The enzyme E δ is advantageously contained in C π on a support other than the face F π of the membrane. E δ can thus be, for example, fixed on an annex membrane or any other suitable support immersed in C ,, or even be dispersed in C π .
La pompe enzymatique selon l'invention a une action de promotion de la diffusion du soluté S au travers de la membrane. Cette action passe par la création et le maintien d'un gradient de concentration ΔS = [Sπ]-[S,] > 0 de part et d'autre de la membrane. La retransformation dans C, et Cπ des métabolites enzymatiques issus des réactions enzymatiques avec Eα et Ep, en solutés S, et/ou S,,, optimise l'effet du pompage. On peut encore compléter cela en conférant à la membrane un effet de clapet par rapport aux métabolites SαI1 produits dans C,,, pour empêcher ces derniers de rediffuser dans C,. Le résultat du pompage enzymatique selon l'invention est le transfert de S, de C, dans C,,. Une fois ce résultat atteint il est aisé de récupérer S,, à des fins d'élimination ou de valorisation.The enzymatic pump according to the invention has an action of promoting the diffusion of the solute S through the membrane. This action involves creating and maintaining a concentration gradient ΔS = [S π ] - [S,]> 0 on either side of the membrane. The retransformation in C, and C π of the enzymatic metabolites resulting from the enzymatic reactions with E α and Ep, in solutes S, and / or S ,,, optimizes the pumping effect. We can further complete this by giving the membrane a valve effect compared to the S αI1 metabolites produced in C ,,, to prevent the latter from re- diffusing in C ,. The result of the enzymatic pumping according to the invention is the transfer of S, from C, into C ,,. Once this result has been achieved, it is easy to recover S ,, for the purpose of elimination or recovery.
Selon an premier mode de fonctionnement du procédé selon l'invention [que l'on peut qualifier de discontinu], la membrane enzymatique se présente sous la forme d'un film mono ou multicouches, de préférence sensiblement plan. Ce mode discontinu correspond, par exemple, au cas de figure dans lequel on a un réacteur formé par un premier conteneur contenant le milieu liquide dans lequel est au moins partiellement immergé un deuxième conteneur. La partie immergée de ce deuxième conteneur étant constituée au moins en partie par la membrane enzymatique poreuse. Ces deux conteneurs définissent les compartiments C, et Cπ. La membrane peut former tout ou partie de la paroi du conteneur. De manière préférée, cette membrane constitue une partie sensiblement plane de la paroi de séparation entre les deux compartiments C, et C,,. Selon an deuxième mode de fonctionnement du procédé selon l'invention,According to the first mode of operation of the method according to the invention [which can be described as discontinuous], the enzymatic membrane is in the form of a monolayer or multilayer film, preferably substantially planar. This discontinuous mode corresponds, for example, to the case in which there is a reactor formed by a first container containing the liquid medium in which a second container is at least partially immersed. The submerged part of this second container being constituted at least in part by the porous enzymatic membrane. These two containers define compartments C, and C π . The membrane can form all or part of the wall of the container. Preferably, this membrane constitutes a substantially flat part of the partition wall between the two compartments C, and C ,,. According to the second mode of operation of the method according to the invention,
(que l'on qualifiera de « continu »), la membrane enzymatique est sous forme tubulaire et plus précisément constitue tout ou partie de la paroi d'un tube, dont la lumière forme l'un des compartiments C,. Avantageusement, la membrane enzymatique peut être faite d'une pluralité de fibres creuses ou membranes tubulaires, de préférence réunis en faisceau(x).(which will be called "continuous"), the enzymatic membrane is in tubular form and more precisely constitutes all or part of the wall of a tube, the lumen of which forms one of the compartments C,. Advantageously, the enzymatic membrane can be made of a plurality of hollow fibers or tubular membranes, preferably united in bundle (x).
Conformément à ce deuxième mode continu de fonctionnement, on fait baigner au moins une partie de cette (ou ces) membrane(s) tubulaire(s) dans le milieu liquide formant l'autre compartiment Cπ et on fait circuler un liquide à appauvrir en soluté S, dans cette (ou ces) membrane(s) enzymatique(s) tubulaire(s). La circulation du liquide dans la ou les membranes tubulaires constituant l'autre compartiments C,, étant assurée par tout moyen approprié tel qu'une pompe.In accordance with this second continuous mode of operation, at least part of this (or these) tubular membrane (s) is immersed in the liquid medium forming the other compartment C π and a liquid to be depleted is circulated in solute S, in this (or these) tubular enzymatic membrane (s). The circulation of the liquid in the tubular membrane or membranes constituting the other compartments C ,, being ensured by any suitable means such as a pump.
A la lecture de ce qui précède, on perçoit aisément l'importance du milieu liquide des compartiments C, et Cπ, et notamment de leurs caractéristiques physicochimiques, pour la conduite du procédé selon l'invention. Ainsi, selon une autre modalité intéressante du procédé selon l'invention, on ajuste les paramètres pH et température des milieux liquides, de manière à obtenir un optima en cinétique et en rendement pour les transformations enzymatiques par Eα et Ep, voire Eδ. En pratique, on élabore donc le milieu liquide de C, et/ou Cπ en ayant recours à un solvant - de préférence essentiellement aqueux -, comprenant éventuellement des solutés choisis dans le groupe suivant : 10On reading the above, one can easily perceive the importance of the liquid medium of compartments C, and C π , and in particular their physicochemical characteristics, for carrying out the process according to the invention. Thus, according to another advantageous modality of the method according to the invention, the pH and temperature parameters of the liquid media are adjusted, so as to obtain an optimum in kinetics and in yield for the enzymatic transformations by E α and E p , or even E δ . In practice, the liquid medium of C, and / or C π is therefore produced by using a solvent - preferably essentially aqueous -, optionally comprising solutes chosen from the following group: 10
• tampons de pH adaptés aux pH optimum de fonctionnement de Eα et Ep, voire Eδ ;• pH buffers adapted to the optimum operating pH of E α and E p , or even E δ ;
• molécules à liaisons riches en énergie - avantageusement ATP ou toute molécule susceptible de transférer un groupement phosphate sur un soluté (par exemple : phosphoénol pyruvate, carbamyl phosphate, phosphocréatine...)• molecules with energy-rich bonds - advantageously ATP or any molecule capable of transferring a phosphate group onto a solute (for example: phosphoenol pyruvate, carbamyl phosphate, phosphocreatine, etc.)
• et leurs mélanges.• and their mixtures.
Outre le réglage du pH et la fourniture de source d'énergie chimique nécessaire aux transformations enzymatiques Eα et Ep, voire Eδ ; on régule également la température des milieux liquides par apport ou évacuation de calories, e.g. réacteur thermostaté avec double paroi de circulation de fluide régulateur de température.In addition to adjusting the pH and supplying the chemical energy source necessary for the enzymatic transformations E α and E p , or even E δ ; the temperature of the liquid media is also regulated by adding or removing calories, eg thermostatically controlled reactor with double wall for circulation of temperature-regulating fluid.
Conformément à l'invention, l'obtention des couches de diffusion di, dπ, s' effectue par mise en mouvement du liquide dans chaque compartiment C,/Cπ, cette mise en mouvement s'opérant par agitation - de préférence à l'aide d'un rotor - dans le premier mode de fonctionnement selon l'invention et/ou par circulation dudit liquide suivant le deuxième mode de fonctionnement du procédé selon l'invention. Par ces biais, on règle les conditions d'agitation et/ou de circulation de façon à ce que la ou les couches de diffusion non turbulentes d, et du aient, en pratique des épaisseurs d'au moins 100 μm. Pour améliorer la cinétique et les performances de transfert du soluté S migrateur, il est possible de prévoir conformément à l'invention, des moyens auxiliaires d'assistance de la migration transmembranaire constitués de préférence par un gradient de force ionique et/ou électrique, de part et d'autre de la membrane, et plus préférentiellement encore par des gradients de pH (force protomotrice). Suivant une disposition préférée de l'invention :In accordance with the invention, the diffusion layers di, dπ, are obtained by setting the liquid in motion in each compartment C, / C π , this setting in motion taking place by stirring - preferably with using a rotor - in the first operating mode according to the invention and / or by circulation of said liquid according to the second operating mode of the method according to the invention. By means of these, the stirring and / or circulation conditions are adjusted so that the non-turbulent diffusion layer or layers d, and d u have, in practice, thicknesses of at least 100 μm. In order to improve the kinetics and the transfer performance of the migrating solute S, it is possible, in accordance with the invention, to provide auxiliary means for assisting the transmembrane migration, preferably consisting of an ionic and / or electrical force gradient, on either side of the membrane, and more preferably still by pH gradients (protomotor force). According to a preferred arrangement of the invention:
• S = S, = S i = Sπ = glucose,• S = S, = S i = S π = glucose,
• Sα = glucose-6-phosphate,• S α = glucose-6-phosphate,
• Eα = glucose-kinase,• E α = glucose kinase,
• Ep = Eδ phosphatase alcaline.• E p = E δ alkaline phosphatase.
POSSIBILITE D'APPLICATION INDUSTRIELLE : Parmi les applications intéressantes du procédé selon l'invention, figurent celles dans lesquelles on réalise l'épuration de liquides physiologiques, de préférence le sang, ce liquide constituant alors le liquide contenu dans C,. Il s'ensuit que la présente invention concerne également un procédé d' hémodialyse. 11POSSIBILITY OF INDUSTRIAL APPLICATION: Among the interesting applications of the method according to the invention, there are those in which the purification of physiological liquids, preferably blood, is carried out, this liquid then constituting the liquid contained in C,. It follows that the present invention also relates to a hemodialysis process. 11
Selon un autre de ses aspects, la présente invention vise un dispositif de dialyse assistée par pompage enzymatique d'au moins un soluté S caractérisé en ce qu'il comprend essentiellement :According to another of its aspects, the present invention relates to a dialysis device assisted by enzymatic pumping of at least one solute S characterized in that it essentially comprises:
• au moins un conteneur d'un milieu liquide ; « au moins une membrane poreuse d'épaisseur em, baignant ou susceptible de baigner dans le milieu liquide, pour délimiter au moins partiellement un compartiment liquide C, destiné à être appauvri en soluté S et au moins partiellement un compartiment liquide C„ destiné à être récepteur du soluté Sj provenant de C,, C,, Cπ contenant respectivement des volumes V, et V,, ;• at least one container of a liquid medium; "At least one porous membrane of thickness em, bathing or capable of bathing in the liquid medium, to at least partially delimit a liquid compartment C, intended to be depleted in solute S and at least partially a liquid compartment C„ intended to be receiver of the solute S j coming from C ,, C ,, C π containing respectively volumes V, and V ,,;
• au moins une enzyme Eα apte à catalyser, dans C,,, la réaction de transformation de S en soluté-produit SαII primaire, Eα étant portée par la membrane sur et/ou dans sa face en regard de Cπ,At least one enzyme E α capable of catalyzing, in C ,,, the reaction of transformation of S into solute-product S αII primary, E α being carried by the membrane on and / or in its face opposite C π ,
• de préférence au moins une enzyme Ep apte à catalyser, dans C,, la réaction de transformation du soluté primaire SαI = SαI1 en soluté- produit secondaire Spι, Ep étant portée par la membrane sur et/ou dans sa face Fj en regard de C,,• preferably at least one enzyme E p able to catalyze, in C ,, the transformation reaction of the primary solute S αI = S αI1 into the solute- secondary product S pι , E p being carried by the membrane on and / or in its face F j opposite C ,,
Ep étant, de manière plus préférée encore, l'enzyme inverse Eα, de sorte que Spι = S, ; • de préférence au moins une enzyme Eδ apte à catalyser dans C,,, la réaction de transformation du soluté primaire SαII en soluté S,,, Eδ étant dispersée dans Cπ sous forme immobilisée ;E p being, even more preferably, the reverse enzyme E α , so that S pι = S ,; • preferably at least one enzyme E δ capable of catalyzing in C ,,, the reaction of transformation of the primary solute S αII into solute S ,,, E δ being dispersed in C π in immobilized form;
• des moyens de mise en mouvement au moins du liquide de Crι et, de préférence, également du liquide de Cr ; • et éventuellement des moyens de réglage de la température du milieu liquide. Ce dispositif est, notamment, adapté à la mise en oeuvre du procédé tel que décrit supra.• means for setting in motion at least the liquid of C rι and, preferably, also of the liquid of C r ; • and possibly means for adjusting the temperature of the liquid medium. This device is, in particular, suitable for implementing the method as described above.
Avantageusement SαI1 et la membrane sont des entités de charges électriques opposées, la (ou les) membrane(s), étant chargée(s), sur au moins l'une de ses faces, de préférence sur F„ portant Eα et plus préférentiellement encore sur les deux.Advantageously S αI1 and the membrane are entities of opposite electrical charges, the membrane (s), being charged, on at least one of its faces, preferably on F „carrying E α and more. preferably still on both.
En pratique, il est préférable que chaque membrane soit électriquement chargée, sur au moins l'une de ses faces, de préférence sur celle adjacente à la face portant l'enzyme Ep et plus préférentiellement encore sur les deux. 12In practice, it is preferable that each membrane is electrically charged, on at least one of its faces, preferably on that adjacent to the face carrying the enzyme E p and more preferably still on both. 12
Conformément à une caractéristique préférée de l'invention, cette membrane enzymatique est une matrice poreuse, dans et/ou sur les deux faces Fπ, F, de laquelle sont incluses et immobilisées les enzymes Eα Ep respectivement, cette matrice étant formée par au moins un composé macromoléculaire, de préférence choisi parmi les protéines, les polysaccharides, les (co)polymères synthétiques et leurs mélanges et/ou alliages, etc, ces composés étant choisis pour leurs porosité, épaisseur, potentiel zêta (charges) et la facilité de greffage de Eα/Ep ; la cellulose et ses dérivés (e.g. acétate de cellulose, cellulose régénérée) de même que les (co)polyamides étant particulièrement préférés. Selon un premier mode de réalisation du dispositif selon l'invention, la membrane enzymatique se présente sous la forme d'un film mono ou multicouche, de préférence sensiblement plan, une fois montée dans le dispositif.According to a preferred characteristic of the invention, this enzymatic membrane is a porous matrix, in and / or on the two faces F π , F, from which are included and immobilized the enzymes E α E p respectively, this matrix being formed by at least one macromolecular compound, preferably chosen from proteins, polysaccharides, synthetic (co) polymers and their mixtures and / or alloys, etc., these compounds being chosen for their porosity, thickness, zeta potential (charges) and ease grafting of E α / E p ; cellulose and its derivatives (eg cellulose acetate, regenerated cellulose) as well as (co) polyamides being particularly preferred. According to a first embodiment of the device according to the invention, the enzymatic membrane is in the form of a monolayer or multilayer film, preferably substantially planar, once mounted in the device.
Selon un deuxième mode de réalisation du dispositif selon l'invention, la membrane enzymatique constitue tout ou partie de la paroi d'au moins un tube dont la lumière forme l'un des compartiments C,.According to a second embodiment of the device according to the invention, the enzymatic membrane constitutes all or part of the wall of at least one tube, the lumen of which forms one of the compartments C,.
Les couples d'enzymes susceptibles d'être mis en oeuvre dans le procédé et le dispositif selon l'invention sont nombreux. Pour fixer les idées on peut indiquer que ces couples Eα/Ep sont principalement choisis parmi les couples d'enzymes permettant l' addition/enlèvement d'un groupement chimique chargé sur un métabolite, de préférence parmi les couples d'enzymes de phosphorylation / déphosphorylation, et plus préférentiellement encore parmi les kinases/phosphatases.There are many pairs of enzymes that can be used in the process and the device according to the invention. To fix the ideas, it may be indicated that these pairs E α / E p are mainly chosen from pairs of enzymes allowing the addition / removal of a charged chemical group on a metabolite, preferably from pairs of phosphorylation enzymes. / dephosphorylation, and more preferably still among kinases / phosphatases.
L'invention sera mieux comprise et ses avantages ou autres variantes de réalisation ressortiront bien de la description qui suit, de deux exemples de réalisation du dispositif qui en fait l'objet. Cette description de dispositif sera complétée par des essais de trois modes de mise en oeuvre du procédé selon l'invention à l'aide des deux dispositifs exemplifiés auparavant.The invention will be better understood and its advantages or other alternative embodiments will become apparent from the description which follows, of two exemplary embodiments of the device which is the subject of it. This description of device will be supplemented by tests of three modes of implementing the method according to the invention using the two devices exemplified before.
BREVE DESCRIPTION DES DESSINS :BRIEF DESCRIPTION OF THE DRAWINGS:
La description des deux modes de réalisation du dispositif selon l'invention sera effectuée en référence aux dessins annexés dans lesquels ;The description of the two embodiments of the device according to the invention will be made with reference to the accompanying drawings in which;
- la fig. 1 représente un schéma simplifié du premier mode de réalisation du dispositif de dialyse assistée par pompage enzymatique, conforme à l'invention (mode discontinu) ;- fig. 1 represents a simplified diagram of the first embodiment of the dialysis device assisted by enzymatic pumping, in accordance with the invention (discontinuous mode);
- la fig. 2 est un schéma simplifié illustrant le deuxième mode de réalisation du dispositif conforme à l'invention (mode continu) ; 13- fig. 2 is a simplified diagram illustrating the second embodiment of the device according to the invention (continuous mode); 13
- la fig. 3 est une représentation symbolique de la membrane enzymatique séparant les deux compartiments C, et C„ du dispositif de la fig. 1 ou 2, ladite représentation correspondant à un mode de mise en oeuvre du procédé de dialyse d'un soluté S, du compartiment C, vers le compartiment Cπ :- fig. 3 is a symbolic representation of the enzymatic membrane separating the two compartments C, and C „of the device of FIG. 1 or 2, said representation corresponding to an embodiment of the dialysis process for a solute S, from compartment C, to compartment C π :
Membrane E S, Su —e→^Membrane E S, Su —e → ^
- la fig. 4 est une représentation symbolique de même nature que la fig. 2, à la différence près qu'elle concerne une 1ère variante de mise en oeuvre du procédé de dialyse du soluté S du compartiment Ci vers le compartiment Cπ :- fig. 4 is a symbolic representation of the same nature as FIG. 2, with the difference that it relates to a 1st variant implementation of the dialysis process of the solute S from compartment Ci to compartment Cπ:
Membrane E Membrane ER Membrane E Membrane E R
S, > Sπ °→ S li » ^T — Ê→ Spi = S, - la fig. 5 est une représentation symbolique de même nature que la fig. 2, à la différence près qu'elle concerne une 2ème variante de mise en oeuvre du procédé de dialyse du soluté S du compartiment Ci vers le compartiment Cπ :S,> S π ° → S li »^ T - Ê → Spi = S, - fig. 5 is a symbolic representation of the same nature as FIG. 2, with the difference that it relates to a second variant of implementation of the dialysis process for the solute S from compartment Ci to compartment Cπ:
Membrane Eα Membrane Eβ Membrane E α Membrane E β
S, 1 >• S„ " + S αïï »- û ςα τl ' s aιβι sS, 1 > • S „" + S αïï ”- û ςα τ l 's a ι β ι s
Eδ E δ
- la fig. 6 est une vue simplifiée en coupe transversale droite selon la ligne VI- VI de la fig. 2 ;- fig. 6 is a simplified view in right cross section along the line VI-VI of FIG. 2;
- la fig. 6 bis est une vue grosssie d'un des éléments de la membrane tubulaire vue en coupe sur la fig. 6 ;- fig. 6 bis is an enlarged view of one of the elements of the tubular membrane seen in section in FIG. 6;
- la fig. 7 représente un graphe des concentrations en SκD), Sπ(„), Scj(0), Sαπ(#) dans Ci, Cπ, en fonction du temps t en min dans l'essai réalisé selon la topographie de la fig. 3,- fig. 7 represents a graph of the concentrations in Sκ D ), Sπ („), Scj ( 0 ), Sαπ ( # ) in Ci, C π , as a function of time t in min in the test carried out according to the topography of FIG. 3
- la fig. 8 montre un graphe des concentrations SK ), Sπc,,), Sαi(0), Sαπ(#), en mM, en fonction du temps t en min, dans l'essai réalisé selon la topographie de la fig. 4 ;- fig. 8 shows a graph of the concentrations SK), Sπc ,,), Sαi ( 0 ), Sαπ (# ), in mM, as a function of time t in min, in the test carried out according to the topography of FIG. 4;
- La fig. 9 représente un graphe des concentrations expérimentales Si( ), Sπ(B), S^o), Sont.) et théorique Sιth (courbe a) en mM en fonction du temps t en min, dans l'essai réalisé selon la topographie de la fig. 5.- Fig. 9 represents a graph of the experimental concentrations Si (), Sπ ( B ), S ^ o ), Sont.) And theoretical Sι th (curve a) in mM as a function of time t in min, in the test carried out according to the topography of fig. 5.
EXPOSE DETAILLE DE L'INVENTION :DETAILED DESCRIPTION OF THE INVENTION:
Le dispositif de séparation et de concentration d'au moins un soluté S à dialyser, selon le premier mode de réalisation de l'invention, est désigné sur la Fig. 1 par la référence générale 1. Ce dispositif ou réacteur 1 est constitué par une cuve 2 14The device for separating and concentrating at least one solute S to be dialyzed, according to the first embodiment of the invention, is designated in FIG. 1 by the general reference 1. This device or reactor 1 is constituted by a tank 2 14
thermostatée présentant une double paroi, prévue pour la circulation d'un fluide thermorégulateur, entre l'entrée 2j et la sortie 22.thermostatically controlled having a double wall, provided for the circulation of a thermoregulating fluid, between the inlet 2 d and the outlet 2 2 .
Cette cuve 2 a, par exemple, une forme générale sensiblement cylindrique creuse et peut être réalisée à partir de tout matériau approprié, métallique, plastique (polymère e.g. du type polyméthacrylate).This tank 2 has, for example, a generally substantially hollow cylindrical shape and can be produced from any suitable material, metallic, plastic (polymer e.g. of the polymethacrylate type).
Cette cuve 2 contient un milieu liquide non référencé sur le dessin et est équipée par ailleurs de moyens d'agitation 3 représentés symboliquement et qui sont avantageusement constitués par un rotor, qui peut être, par exemple, un barreau magnétique fonctionnant avec un agitateur magnétique, ou bien encore une hélice d'agitation classique.This tank 2 contains a liquid medium not referenced in the drawing and is also equipped with stirring means 3 symbolically represented and which are advantageously constituted by a rotor, which can be, for example, a magnetic bar operating with a magnetic stirrer, or even a conventional stirring propeller.
Un corps tubulaire 4 contenant également du milieu liquide, baigne partiellement dans le milieu liquide contenu dans la cuve 2. Ce corps tubulaire 4 présente avantageusement une section transversale droite circulaire. L'extrémité inférieure immergée de ce corps tubulaire 4 est obturée par une membrane enzymatique 5 insérée entre deux joints 6 périphériques annulaires, constitués - par exemple - de matière plastique paraffinique. La membrane 5 est solidarisée avec le corps tubulaire 4 par l'intermédiaire d'une lèvre 7 ou d'un rebord annulaire ménagé à l'extrémité libre immergée dudit corps tubulaire. Les moyens de fixation utilisés sont par exemple des vis et écrous 8, e.g. en téflon. Le corps tubulaire 4 est équipé de moyens d'agitation 9, du type agitateur à pale. Les niveaux de liquide dans la cuve 2 (1er conteneur) et dans le corps tubulaire 4 (2ème conteneur) sont ajustés de telle sorte qu'ils soient identiques.A tubular body 4 also containing liquid medium, partially bathes in the liquid medium contained in the tank 2. This tubular body 4 advantageously has a circular cross section. The submerged lower end of this tubular body 4 is closed by an enzymatic membrane 5 inserted between two annular peripheral seals 6, made - for example - of paraffinic plastic. The membrane 5 is secured to the tubular body 4 via a lip 7 or an annular rim formed at the free immersed end of said tubular body. The fixing means used are for example screws and nuts 8, e.g. Teflon. The tubular body 4 is equipped with stirring means 9, of the paddle type agitator. The liquid levels in the tank 2 (1st container) and in the tubular body 4 (2nd container) are adjusted so that they are identical.
La membrane enzymatique 5 d'extrémité, délimite avec la paroi du tube 4 le compartiment référencé par C, sur la Fig. 1. Cette membrane 5 sépare également ledit compartiment C, du compartiment Cπ constitué par la cuve 2 remplie de milieu liquide.The end enzymatic membrane 5, with the wall of the tube 4, delimits the compartment referenced by C, in FIG. 1. This membrane 5 also separates said compartment C, from compartment C π constituted by the tank 2 filled with liquid medium.
Dans cet exemple, le volume interne V, du compartiment C, = 1,5 cm3, tandis que le volume V,, du compartiment Cu = 300 cm3. Conformément à l'invention, la membrane 5 est réalisée en polymère naturel modifié ou non ou en polymère de synthèse. En l'occurence, il s'agit ici d'une membrane en polyamide commercialisée par Pall Europe limited, Portsmouth England sous la référence Pall NAZ se présentant sous la forme de matériau non tissé, ayant une épaisseur de 100 μm e.g. La porosité de cette membrane est définie par le seuil de coupure, ce dernier étant naturellement choisi en fonction de la taille des molécules que l'on souhaite faire migrer au travers de la membrane pour les surconcentrer dans un compartiment. Exprimé en poids moléculaire maximum pour les molécules 15In this example, the internal volume V, of compartment C, = 1.5 cm 3 , while the volume V ,, of compartment C u = 300 cm 3 . According to the invention, the membrane 5 is made of natural polymer, modified or not, or of synthetic polymer. In this case, it is a polyamide membrane sold by Pall Europe limited, Portsmouth England under the reference Pall NAZ, in the form of nonwoven material, having a thickness of 100 μm eg The porosity of this membrane is defined by the cutoff threshold, the latter being naturally chosen as a function of the size of the molecules which it is desired to migrate through the membrane to overconcentrate them in a compartment. Expressed in maximum molecular weight for molecules 15
susceptibles de migrer au travers des pores, ce seuil de coupure est avantageusement compris entre 500 et 10 000 D, selon la taille des molécules que l'on veut surconcentrer.likely to migrate through the pores, this cut-off threshold is advantageously between 500 and 10 000 D, depending on the size of the molecules that one wants to over-concentrate.
Selon une variante, cette membrane peut également être constituée de cellulose régénérée et se présente sous la forme d'un film non tissé d'épaisseur comprise entreAlternatively, this membrane can also be made of regenerated cellulose and is in the form of a nonwoven film of thickness between
10 et 100 μm.10 and 100 μm.
Chacune des faces Fπ, Fi de la membrane 5 en regard, respectivement, du compartiment C,, et du compartiment C,, a été soumise à un greffage d'enzymesEach of the faces F π , Fi of the membrane 5 opposite, respectively, of compartment C ,, and of compartment C ,, has been subjected to a grafting of enzymes
Eα/Ep, formant un couple d'enzymes réversibles dans lequel l'enzyme Eα est apte à catalyser la transformation de Sπ en Sαπ et l'enzyme Ep la transformation de Sα, en Si.E α / E p , forming a pair of reversible enzymes in which the enzyme E α is able to catalyze the transformation of S π into S α π and the enzyme E p the transformation of S α , into Si.
Le greffage de l'enzyme peut être de nature covalente ou bien encore une simple inclusion de l'enzyme par adsorption au sein de la matrice polymère fibreuse.The grafting of the enzyme can be of covalent nature or even a simple inclusion of the enzyme by adsorption within the fibrous polymer matrix.
Le greffage covalent peut être réalisé selon les techniques classiques. Les exemples qui suivent donne une illustration du greffage enzymatique. Le deuxième mode de réalisation du dispositif selon l'invention est représenté sur la fig. 2, sur laquelle il est désigné par la référence générale 10. Ce dispositif 10 de dialyse de Ci-» Cπ d'un soluté S est apte à fonctionner selon un mode continu.Covalent grafting can be carried out according to conventional techniques. The examples which follow give an illustration of the enzymatic grafting. The second embodiment of the device according to the invention is shown in FIG. 2, on which it is designated by the general reference 10. This device 10 for dialysis of Ci- »Cπ of a solute S is capable of operating in a continuous mode.
Ce dispositif 10 comprend une cuve 11 thermostatée du même type que celle (2) décrite dans le premier mode de réalisation de la Fig. 1. Les références llj etThis device 10 comprises a thermostatically controlled tank 11 of the same type as that (2) described in the first embodiment of FIG. 1. References ll j and
112 désignent respectivement l'entrée et la sortie du circuit de circulation d'un fluide thermorégulateur dans la double enveloppe de la cuve 11.11 2 respectively designate the inlet and the outlet of the circulation circuit of a thermoregulatory fluid in the jacket of the tank 11.
Cette cuve 11 contient le milieu liquide contenant initialement le soluté S et constituant le compartiment liquide Cπ. Des moyens 12 d'agitation mécanique sont prévus au sein de ce milieu liquide formant C,,. Ces moyens d'agitation 12 sont du même type que ceux décrits pour le premier mode de réalisation représenté à la Fig. 1 et désignés par la référence 9 dans cette figure.This tank 11 contains the liquid medium initially containing the solute S and constituting the liquid compartment C π . Means 12 of mechanical agitation are provided within this liquid medium forming C ,,. These stirring means 12 are of the same type as those described for the first embodiment shown in FIG. 1 and designated by the reference 9 in this figure.
Dans ce deuxième mode de réalisation, la membrane enzymatique est constituée par une pluralité de tube 13 à paroi poreuse et regroupés entre eux pour former un faisceau 14, dont une partie est immergée dans le milieu liquide de la cuveIn this second embodiment, the enzymatic membrane consists of a plurality of tubes 13 with porous walls and grouped together to form a bundle 14, part of which is immersed in the liquid medium of the tank.
11 (Cπ).11 (Cπ).
En fait, les lumières des tubes 13 constitue autant de compartiments C, liquides, intervenant dans le procédé selon l'invention.In fact, the lights of the tubes 13 constitute as many compartments C, liquid, involved in the method according to the invention.
Les flèches indiquées sur la fig. 1 dans le faisceau 13 donne le sens de circulation du flux des compartiments C,.The arrows shown in fig. 1 in the bundle 13 gives the direction of flow of the flow of the compartments C ,.
La coupe de la fig. 6 montre le faisceau 14 de membranes enzymatiques tubulaires 13. 16The section in fig. 6 shows the bundle 14 of tubular enzymatic membranes 13. 16
Ce faisceau 14 présente une partie recourbée en forme de U, dont la base plonge dans le compartiment Cπ liquide défini par la cuve 11. Ce faisceau tubulaire 14 est destiné à permettre la circulation de milieu liquide à appauvrir en soluté S par migration active transmembranaire. A cette fin, le faisceau 14 est équipé de moyens de mise en circulation 15 constitués, par exemple, par une pompe.This bundle 14 has a curved U-shaped part, the base of which dips into the liquid compartment C π defined by the tank 11. This tubular bundle 14 is intended to allow the circulation of liquid medium to be depleted in solute S by active transmembrane migration . To this end, the bundle 14 is equipped with circulating means 15 constituted, for example, by a pump.
La fig. 6 bis est une vue en coupe transversale droite d'une membrane enzymatique tubulaire 13 constituant le faisceau 14 et délimitant par l'intermédiaire de sa paroi, d'une part, un compartiment C, interne (lumière du tube), et d'autre part, pour ce qui concerne la partie immergée du faisceau 14, un compartiment Cπ extérieur, défini par la cuve 11. A l'instar de la membrane 5 de la fig. 1, la paroi du tube 13 comprend sur chacune de ces faces interne et externe une enzyme Eα et Ep respectivement, constituant un couple d'enzymes réversibles. Les méthodes de fixation et d'immobilisation des enzymes sont les mêmes que celles décrites supra. En outre, les matériaux constitutifs de ces membranes tubulaires sont eux aussi de même nature que ceux évoqués pour la membrane 5 de la fig. 1. En pratique, il s'agira par exemple de cellulose régénérée de nature poreuse, présentant un seuil de coupure pouvant varier de 500 à 10 000 D.Fig. 6 bis is a right cross-sectional view of a tubular enzymatic membrane 13 constituting the bundle 14 and delimiting through its wall, on the one hand, an internal compartment C (tube lumen), and on the other hand on the other hand, with regard to the submerged part of the bundle 14, an external compartment C π , defined by the tank 11. Like the membrane 5 of FIG. 1, the wall of the tube 13 comprises on each of these internal and external faces an enzyme E α and E p respectively, constituting a pair of reversible enzymes. The methods of fixing and immobilizing the enzymes are the same as those described above. In addition, the constituent materials of these tubular membranes are also of the same nature as those mentioned for the membrane 5 of FIG. 1. In practice, this will, for example, be regenerated cellulose of a porous nature, having a cut-off threshold which may vary from 500 to 10,000 D.
Les moyens d'agitation 12 de la cuve 11 ainsi que la mise en mouvement du liquide de C, dans les fibres creuses 13 à l'aide de la pompe 15, permettent de définir des couches de diffusion dj et dπ, montrés sur la fig. 6 bis. Cette dernière fait également apparaître le diamètre interne D de la fibre creuse 13, de même que l'épaisseur em de la paroi membranaire chargée d'enzymes Eα/Ep.The stirring means 12 of the tank 11 as well as the setting in motion of the liquid of C, in the hollow fibers 13 by means of the pump 15, make it possible to define diffusion layers d j and d π , shown on fig. 6 bis. The latter also shows the internal diameter D of the hollow fiber 13, as well as the thickness em of the membrane wall charged with enzymes E α / E p .
La somme des volumes des compartiments C, immergés dans C,, est inférieure au volume Vπ du compartiment Cπ. Le rapport V V,, est le plus faible possible.The sum of the volumes of compartments C, immersed in C ,, is less than the volume V π of compartment C π . The VV ratio is as low as possible.
Les membranes tubulaires 13 peuvent être électriquement chargées en positif ou en négatif, de manière à éviter la diffusion parasite de Son dans Ci.The tubular membranes 13 can be electrically charged in positive or in negative, so as to avoid the parasitic diffusion of Sound in Ci.
Ce deuxième mode de réalisation du dispositif selon l'invention est adapté au deuxième mode de mise en oeuvre continu du procédé de dialyse. On retrouve la même méthodologie employée que pour le premier mode discontinu de mise en oeuvre, à la différence près que le milieu liquide des compartiments C, circule dans les fibres creuses 13 enzymatiques, le transport actif transmembranaire de S s' opérant naturellement au niveau de la partie immergée du faisceau 14 dans le compartiment Cn liquide de la cuve 11. La vitesse de circulation du milieu liquide des compartiments C, est adaptée à la surface totale de la zone d'échange dans la partie immergée, des 17This second embodiment of the device according to the invention is adapted to the second continuous mode of implementation of the dialysis process. We find the same methodology used as for the first discontinuous mode of implementation, with the difference that the liquid medium of compartments C circulates in the hollow enzymatic fibers 13, the active transmembrane transport of S 'occurring naturally at the submerged part of the bundle 14 in the liquid compartment C n of the tank 11. The speed of circulation of the liquid medium in the compartments C is adapted to the total surface of the exchange zone in the submerged part, 17
cinétiques de transformation enzymatique Eα/Ep, ainsi que des vitesses de diffusion transmembranaire du soluté S.kinetics of enzymatic transformation E α / E p , as well as transmembrane diffusion rates of solute S.
La représentation symbolique de la fig. 3 montre la membrane 5 portant dans sa face Fπ en regard de Cπ l'enzyme Eα. Cette membrane présente une épaisseur em. Elle est attenante par sa face Fπ avec une couche de diffusion dπ et par sa face Fi en regard de Ci avec une autre couche de diffusion di, d'épaisseur edi. Selon que le soluté S est dans Ci ou dans Cπ, la référence S comprend l'indice I ou II séparé par une virgule du paramètre t correspondant au temps. Selon que le soluté S est dans une couche de diffusion ou dans le reste du compartiment Ci ou Cπ, la référence S comprend en exposant les lettres d et b (b pour "bulk" en anglais) respectivement. Le deuxième exposant de la référence S correspond à la charge négative (-) ou neutre (o) du soluté.The symbolic representation of fig. 3 shows the membrane 5 carrying in its face Fπ opposite Cπ the enzyme E α . This membrane has a thickness em. It is adjoined by its face Fπ with a diffusion layer d π and by its face Fi opposite Ci with another diffusion layer di, of thickness edi. Depending on whether the solute S is in Ci or in Cπ, the reference S includes the index I or II separated by a comma from the parameter t corresponding to time. Depending on whether the solute S is in a diffusion layer or in the rest of the compartment Ci or C π , the reference S includes by exposing the letters d and b (b for "bulk" in English) respectively. The second exponent of the reference S corresponds to the negative (-) or neutral (o) charge of the solute.
Au temps t = 0 on a : S^ t ≠ o ; Sb π,t = Sbαπ,t = Sbαi,t = 0. Au temps t, le soluté Si a migré au travers de la membrane pour passer de Ci vers Cπ. Et c'est dans la couche de diffusion dπ de Cπ que Sπ est transformé en Son par Eα. La partie de Sπ qui n'est pas métabolisée par Eα diffuse dans le compartiment Cπ. Une partie de Son traverse la membrane pour passer dans le compartiment Ci, de sorte que ce dernier comprend du soluté Soi dans sa couche de diffusion et dans le reste du compartiment. Une partie de Son diffuse également dans le compartiment Cπ tout entier.At time t = 0 we have: S ^ t ≠ o; S b π , t = S b απ, t = S b αi, t = 0. At time t, the solute Si has migrated through the membrane to pass from Ci to C π . And it is in the diffusion layer dπ of Cπ that S π is transformed into Sound by E α . The part of S π which is not metabolized by E α diffuses into the Cπ compartment. Part of the bran passes through the membrane to pass into the compartment Ci, so that the latter comprises self-solute in its diffusion layer and in the rest of the compartment. Part of the Sound also plays in the entire C π compartment.
La fig. 4 représente de manière synoptique la topographie propre à la première variante de mise en oeuvre du procédé conforme à l'invention. Les faces Fπ et Fi de la membrane sont respectivement porteuses des enzymes réversibles Eα/ Ep. Le soluté Si traverse la membrane pour passer de Ci dans Cπ et pour être en partie métabolisé dans la couche de diffusion dπ attenante à la face Fπ de Cπ, en soluté Son, par l'enzyme Eαi. Une partie de Son diffuse au travers de la membrane de Cπ vers Ci et le composé Soi ayant ainsi diffusé et transformé en Si dans la couche de diffusion di attenante à Si, par l'enzyme Ep. Sπ et Son diffusent dans Cπ, de même que Soi diffuse dans Ci. La membrane est, de préférence, chargée électriquement de même signe que Son, en l'occurrence négativement, de manière à limiter la diffusion de Son dans Ci.Fig. 4 schematically represents the topography specific to the first variant of implementation of the method according to the invention. The Fπ and Fi faces of the membrane respectively carry the reversible enzymes E α / Ep. The solute Si crosses the membrane to pass from Ci into C π and to be partly metabolized in the diffusion layer dπ adjoining the face F π of Cπ, in solute Son, by the enzyme Eαi. A part of its diffuse through the membrane of Cπ towards Ci and the compound Soi having thus diffused and transformed into Si in the diffusion layer di adjoining Si, by the enzyme Ep. Sπ and Son diffuse in Cπ, similarly that Self diffuses in Ci. The membrane is preferably electrically charged with the same sign as Sound, in this case negatively, so as to limit the diffusion of Sound in Ci.
La fig. 5 correspond à la deuxième variante de mise en oeuvre du procédé selon l'invention. On retrouve le même schéma que celui de la fig. 4, à la différence près que le compartiment Cπ comprend une enzyme Eδ apte à métaboliser Son en Sπ, cette transformation s'opérant, de préférence, dans la partie de Cπ différente de la couche de diffusion non turbulente dπ. 18Fig. 5 corresponds to the second variant of implementation of the method according to the invention. We find the same diagram as that of fig. 4, with the difference that the compartment Cπ comprises an enzyme E δ capable of metabolizing Sound to S π , this transformation taking place preferably in the part of Cπ different from the non-turbulent diffusion layer dπ. 18
Dans les mises en oeuvre correspondantes au schéma des fig. 3 à 5, le pompage enzymatique, assuré par Eα, Ep et Eδ, provoque la formation d'un gradient de concentration Δ[S] = [S2] - [Si] > 0.In the implementations corresponding to the diagram of FIGS. 3 to 5, the enzymatic pumping, provided by E α , Ep and E δ , causes the formation of a concentration gradient Δ [S] = [S 2 ] - [Si]> 0.
Les exemples qui suivent illustrent le procédé selon l'invention dans ses trois modes préférés de mise en oeuvre. Ces exemples permettront de mieux comprendre les sens de l'invention et d'en saisir tous ses avantages et variantes de mise en oeuvre.The examples which follow illustrate the process according to the invention in its three preferred modes of implementation. These examples will make it possible to better understand the meanings of the invention and to grasp all of its advantages and implementation variants.
EXEMPLES EXEMPLE 1 : DIALYSE ASSISTÉE PAR POMPAGE ENZYMATIQUE D'UNEXAMPLES EXAMPLE 1: ASSISTED DIALYSIS BY ENZYMATIC PUMPING OF A
SOLUTE S = GLUCOSE, D'UN COMPARTIMENT LIQUIDE Cj, VERS UN COMPARTIMENT CJJ SELON LE 1er MODE DE MISE EN OEUVRE DU PROCEDE DE L'INVENTION ET A L'AIDE DU DISPOSITIF DE L'INVENTION DANS SON 1er MODE DE REALISATIONSOLUTE S = GLUCOSE, FROM A LIQUID COMPARTMENT Cj, TOWARDS A COMPARTMENT CJJ ACCORDING TO THE 1 st MODE OF IMPLEMENTING THE PROCESS OF THE INVENTION AND USING THE DEVICE OF THE INVENTION IN ITS 1 ST EMBODIMENT
1. 1. Matériel Le dispositif mis en oeuvre est celui décrit supra et représenté sur la fig. 1.1. 1. Equipment The device used is that described above and shown in FIG. 1.
Les membranes de dialyse mises en oeuvre sont des membranes du type Pall NAZ commercialisées par la société PALL EUROP LIMITED. Ce sont des membranes en polyamide d'épaisseur égale à 100 μm de surface active de transfert (Aw) de 12 % et référencées sous le numéro 09025. On utilise également des membranes de dialyse en cellulose régénérés, d'épaisseur 40 μm, commercialisées sous la dénomination spectra / Por. 3500 MWCO - réf 132723 par la société spectrum. Ces membranes de dialyse sont celles qui ne portent pas d'enzymes. L'enzyme Eα = glycérolkinase - GK - (EC2.7.1.30) provenant de l'espèce cellulomonas (52 unités. mg-1, ref.g. 6142).The dialysis membranes used are membranes of the Pall NAZ type sold by the company PALL EUROP LIMITED. These are polyamide membranes with a thickness equal to 100 μm of active transfer area (Aw) of 12% and referenced under the number 09025. We also use regenerated cellulose dialysis membranes, with a thickness of 40 μm, sold under the name spectra / Por. 3500 MWCO - ref 132723 by spectrum. These dialysis membranes are those that do not carry enzymes. The enzyme E α = glycerolkinase - GK - (EC2.7.1.30) from the species cellulomonas (52 units. Mg -1 , ref.g. 6142).
Ep = Eδ phosphatase alcaline -PA- (EC3.1.3.1.) extraite de muqueuse intestinale bovine (1200 Unités.mg"1, réf. P 6672).E p = E δ alkaline phosphatase -PA- (EC3.1.3.1.) Extracted from bovine intestinal mucosa (1200 Units.mg " 1 , ref. P 6672).
Les enzymes Eα, Ep et Eδ définies ci-dessus sont commercialisées par la société SIGMA. L'immobilisation des enzymes sur la membrane s'opère de la façon suivante :The enzymes E α , E p and E δ defined above are marketed by the company SIGMA. The immobilization of the enzymes on the membrane operates as follows:
Les membranes se présentent sous la forme de disques de 5 cm de diamètre que l'on active à l'aide d'une solution d'acide sulfurique dans le méthanol sous reflux pendant 6 heures. On les soumet ensuite à l'action d'une solution de glutaraldéhyde à 2 % V/V, comme décrit dans l'article de Michalon, P., Couturier, R., Hacques, M-F., Favre-Bonvin, G, Ville, A. & Marion, C. (1990) Biochem. Biophys. Res. Commun, 167, 9-15. 19The membranes are in the form of discs 5 cm in diameter which are activated using a solution of sulfuric acid in methanol under reflux for 6 hours. They are then subjected to the action of a 2% V / V glutaraldehyde solution, as described in the article by Michalon, P., Couturier, R., Hacques, MF., Favre-Bonvin, G, Ville , A. & Marion, C. (1990) Biochem. Biophys. Res. Common, 167, 9-15. 19
Le greffage des enzymes Eα = GK et Ep = Eδ = PA est réalisé en immergeant les disques à température ambiante pendant 3 heures dans 5 cm3 d'une solution d'enzyme titrant 2 mg. cm*3 et 0,2 mg. cm'3 pour la GK et la phosphatase respectivement, dans un tampon borate 0,1 M, pH 8,5. Le volume de Cf = 1,5 cm3 et le volume de Cπ = 300 cm3.The grafting of the enzymes E α = GK and Ep = E δ = PA is carried out by immersing the discs at room temperature for 3 hours in 5 cm 3 of an enzyme solution titrating 2 mg. cm * 3 and 0.2 mg. cm ' 3 for GK and phosphatase respectively, in a 0.1 M borate buffer, pH 8.5. The volume of C f = 1.5 cm 3 and the volume of C π = 300 cm 3 .
1.2. Conditions opératoires1.2. Operating conditions
Les milieux liquides en C, et Cπ ont la même composition à l'exception des concentrations en composé A = glycérol-3 -phosphate2" et en composé B = glycérol. La température du milieu liquide est thermostatée par la cuve à 25 ° C. Les autres conditions opératoires varient en fonction des essais réalisés.The liquid media in C and C π have the same composition with the exception of the concentrations of compound A = 2 -glycerol-3-phosphate and of compound B = glycerol. The temperature of the liquid medium is thermostatically controlled by the tank at 25 °. C. The other operating conditions vary according to the tests carried out.
1.3. Essais selon la topographie de la fig. 31.3. Tests according to the topography of fig. 3
Dans cet essai, les milieux liquides C[/Cπ contiennent du tampon borate 0, 1 M en quantité telle que le pH soit de l'ordre de 9 ainsi que de l'ATP Mg Cl2 - 7 mM. S= Si = Sπ = glucose. Son = Soi = glucose -6-phosphate (G-6-P"). Eα= GK. Les réactions enzymatiques mises en oeuvre dans les exemples sont les suivantes :In this test, the liquid media C [ / C π contain 0.1 M borate buffer in an amount such that the pH is of the order of 9 as well as ATP Mg Cl 2 - 7 mM. S = Si = Sπ = glucose. Son = Soi = glucose -6-phosphate (G-6-P " ). E α = GK. The enzymatic reactions used in the examples are as follows:
MgCl2/ATP + glucose — ^ — ^ glucose-6-phosphate +ADP/MgCl2 MgCl 2 / ATP + glucose - ^ - ^ glucose-6-phosphate + ADP / MgCl 2
PA G-6-P »- glucose + phosphate Les concentrations en glucose sont déterminées à partir d'échantillons prélevés dans les compartiments Ci et Cπ, en utilisant un capteur formé par une électrode enzymatique composée par une sonde ampérométrique au platine associée à une membrane en nylon chargée en glucose oxydase, cette sonde étant couplée à un polarographe de type PRGE de la société RADIOMETER (VILLEURBANNE, FRANCE), (THEVENOT et al) , 1979. Ce biocapteur permet les déterminations de concentration en glucose selon la réaction suivante : glucose oxydase D-glucose + O2 ^ acide gluconique + H2O2 PA G-6-P "- glucose + phosphate The glucose concentrations are determined from samples taken in the compartments Ci and Cπ, using a sensor formed by an enzymatic electrode composed by an amperometric platinum probe associated with a membrane nylon loaded with glucose oxidase, this probe being coupled to a PRGE type polarograph from the company RADIOMETER (VILLEURBANNE, FRANCE), (THEVENOT et al), 1979. This biosensor allows glucose concentration determinations according to the following reaction: glucose oxidase D-glucose + O 2 ^ ac ide gluconic + H 2 O 2
Pt/anode(650mV)VsAg/AgClPt / anode (650mV) VsAg / AgCl
H2°2 O2+2H++2e" H 2 ° 2 O 2 + 2H + + 2e "
Le courant anodique ainsi obtenu est proportionnel aux concentrations d'H2O2, qui sont elles-même proportionnelles aux concentrations en glucose.The anode current thus obtained is proportional to the H 2 O 2 concentrations, which are themselves proportional to the glucose concentrations.
L'épaisseur em de la membrane de dialyse chargée en GK en regard de Cπ est de 240 μm.The thickness em of the dialysis membrane loaded with GK opposite Cπ is 240 μm.
Les conditions d'agitation de cet essai sont respectivement de 180 révolutions / min et 100 revolutions/min dans Ci et Cπ. 20The stirring conditions of this test are respectively 180 revolutions / min and 100 revolutions / min in Ci and C π . 20
Ces conditions permettent d'obtenir les épaisseurs de couche de diffusion di et dπ qui sont :These conditions make it possible to obtain the thicknesses of diffusion layer di and dπ which are:
- edi = 100 μm.- edi = 100 μm.
- edπ = 180 μm. Lors du déroulement des essais, des échantillons de G-6-P" sont prélevés dans les deux compartiments Ci et Cπ et analysés à l'aide de G-6-P" déshydrogènase en mesurant l'augmentation de l'absorption à 340 nm associés à la réduction de NADP+ (Lang and Michal, 1974). La détermination des activités enzymatiques des membranes NAZ chargés en GK et en PA, est effectuée de la manière suivante.- edπ = 180 μm. During the course of the tests, samples of G-6-P "are taken from the two compartments Ci and Cπ and analyzed using G-6-P" dehydrogenase by measuring the increase in absorption at 340 nm associated with reduction of NADP + (Lang and Michal, 1974). The determination of the enzymatic activities of the NAZ membranes loaded with GK and PA is carried out in the following manner.
Les disques de NAZ chargés en GK sont immergés dans un ml de tampon borate de 0,1 M pH 8,5 contenant 7mM ATP/MgCl2 en présence d'une concentration saturante en glucose, c'est-à-dire 0,2 M, et ce à 25° C. Des échantillons sont prélevés chaque 5 min pendant 20 min. On mesure dans ces échantillons, la concentration en G-6-P", de façon à déterminer l'activité GK.The NAZ discs loaded with GK are immersed in a ml of 0.1 M borate buffer pH 8.5 containing 7 mM ATP / MgCl 2 in the presence of a saturated concentration of glucose, i.e. 0.2 M, at 25 ° C. Samples are taken every 5 min for 20 min. In these samples, the G-6-P "concentration is measured, so as to determine the GK activity.
De la même façon des disques de NAZ chargés en PA sont immergés dans 5 ml d'un tampon borate 0,1 M, pH 8,5 en présence de 33 mM de G-6-P" (concentration saturante). Des échantillons sont prélevés chaque 5 min pendant 20 min et on mesure dans ceux-ci la concentration en glucose pour déduire l'activité PA. Le milieu liquide de Ci, Cπ est constitué par du tampon phosphate 0, 1 M contenant 7 mM d'ATP/MgCl2, à pH 8,5 et à 25° C. Su b'° = S, » ≈ S2 -° = S2> tb-° = 2 mM.Similarly, NAZ disks loaded with PA are immersed in 5 ml of 0.1 M borate buffer, pH 8.5 in the presence of 33 mM G-6-P "(saturation concentration). Samples are sampled every 5 min for 20 min and the glucose concentration is measured in these to deduce the PA activity. The liquid medium of Ci, Cπ consists of 0.1 M phosphate buffer containing 7 mM ATP / MgCl 2 , at pH 8.5 and at 25 ° C. S u b '° = S, » ≈ S 2 - ° = S 2> tb - ° = 2 mM.
La fig. 7 montre clairement la diminution de la concentration Si en glucose dans le compartiment qui est beaucoup plus marquée que la décroissance de Sπ, bien que la réaction enzymatique promue par Eα = GK intervienne seulement dans Cπ. Par ailleurs, la concentration Son en G-6-P" dans Cπ croît moins vite que la concentration Soi en G-6-P" dans le compartiment Ci non enzymatique.Fig. 7 clearly shows the decrease in the glucose concentration Si in the compartment which is much more marked than the decrease in Sπ, although the enzymatic reaction promoted by E α = GK occurs only in Cπ. Furthermore, the concentration of Son in G-6-P "in Cπ increases more slowly than the concentration of Self in G-6-P" in the non-enzymatic compartment Ci.
EXEMPLE 2 : ESSAIS SELON LA TOPOGRAPHIE DE LA FIG. 4 Dans ces essais, la membrane de dialyse comprend une membrane NAZ chargée en Eα= GK en regard de Cπ, une membrane NAZ chargée en Ep = PA en regard de Ci et une membrane spectra /Por intercalée entre ces deux membranes enzymatiques. La membrane de dialyse a une épaisseur em = de 240 μm. Les conditions d'agitation sont de 180 révolutions/min et 100 révolutions/min dans Ci et Cπ respectivement.EXAMPLE 2: TESTS ACCORDING TO THE TOPOGRAPHY OF FIG. 4 In these tests, the dialysis membrane comprises a membrane NAZ charged with E α = GK opposite C π , a membrane NAZ charged with Ep = PA opposite Ci and a spectra / Por membrane interposed between these two enzymatic membranes. The dialysis membrane has a thickness em = of 240 μm. The stirring conditions are 180 revolutions / min and 100 revolutions / min in Ci and Cπ respectively.
De telles conditions déterminent des épaisseurs pour dr et dπ qui sont : 21Such conditions determine thicknesses for dr and dπ which are: 21
- edι= 100 μm.- edι = 100 μm.
- dπ = 180 μm.- d π = 180 μm.
Les autres conditions expérimentales sont identiques à celles décrites ci-dessus dans l'exemple 1. La fig. 8 montre clairement que le G-6-P" produit dans Cπ (Son) ne pollue pas C, ; Soi est constant et est égal à 0. Par ailleurs la concentration Si en glucose dans Ci décroît rapidement en 500 min. La concentration Sπ en glucose dans Cπ décroît moins rapidement que Si tandis que Son croît régulièrement.The other experimental conditions are identical to those described above in Example 1. FIG. 8 clearly shows that the G-6-P " produced in Cπ (Son) does not pollute C,; S o i is constant and is equal to 0. Furthermore, the concentration Si of glucose in Ci decreases rapidly in 500 min. S π glucose concentration in Cπ decreases less rapidly than Si while Son increases regularly.
EXEMPLE 3 : ESSAIS DE DIALYSE DE GLUCOSE SELON LA TOPOGRAPHIE DE LA FIG. 5EXAMPLE 3: GLUCOSE DIALYSIS TESTS ACCORDING TO THE TOPOGRAPHY OF FIG. 5
Dans cet essai, on retrouve la même topographie qu'à la fig. 4, à la différence près que le compartiment Cπ contient une enzyme Es = PA, qui est amenée par l'intermédiaire de 4 disques de membrane NAZ chargés en PA. Cette dernière a pour vocation de transformer le glucose-6-phosphate présent dans Cπ. Les conditions expérimentales sont les mêmes que dans les exemples 1 et 2 précédents.In this test, we find the same topography as in fig. 4, with the difference that compartment Cπ contains an enzyme E s = PA, which is supplied via 4 NAZ membrane disks loaded with PA. The latter is intended to transform the glucose-6-phosphate present in Cπ. The experimental conditions are the same as in Examples 1 and 2 above.
Les conditions d'agitation sont les mêmes que dans les exemples 1 et 2 précédents. Ces conditions déterminent une épaisseur edi = lOOμrn pour la couche de diffusion dπ et edπ = 180 μm pour la couche de diffusion dπ. L'épaisseur de la membrane de dialyse est em = 240 μm. La fig. 9 montre les résultats obtenus et il ressort qu'aucune pollution du compartiment I par le G-6-P" produit dans Cπ n'intervient. De même, la concentration Son reste constamment nulle dans Cπ. Par ailleurs à partir de t = 500 min, on observe un écart ΔS = [Sπ]-[Sτ] constant et compris entre 0,5 et 1 mM. La comparaison des courbes Sιth et Si = f(t), montre une bonne corrélation entre le modèle théorique et le modèle expérimental.The stirring conditions are the same as in Examples 1 and 2 above. These conditions determine a thickness edi = lOOμrn for the diffusion layer d π and edπ = 180 μm for the diffusion layer dπ. The thickness of the dialysis membrane is em = 240 μm. Fig. 9 shows the results obtained and it appears that no pollution of compartment I by the G-6-P "produced in Cπ occurs. Likewise, the concentration S o n remains constantly zero in Cπ. Furthermore from t = 500 min, we observe a constant ΔS = [Sπ] - [Sτ] deviation between 0.5 and 1 mM. The comparison of the curves Sι th and Si = f (t), shows a good correlation between the theoretical model and the experimental model.
Il ressort de ce qui précède qu'une dialyse de glucose assistée par un pompage enzymatique résultant d'un mécanisme enzymatique et cyclique de phosphorylation / déphosphorylation, de part et d'autre de la membrane dans les compartiments Cπ d'arrivée et Ci de départ, s'avère tout à fait efficace, sélective et offre de bons rendements sans nécessiter l'emploi de gros volumes de dialysats. Ce mécanisme est encore optimisé dès lors que l'on prévoit une déphosphorylation G-6-P" hors de la couche de diffusion dπ du compartiment Cπ. La phosphorylation / déphosphorylation interviennent respectivement dans dπ et di. Dans tous ces essais, la membrane est chargée négativement comme le G-6-P" de manière à limiter la diffusion de celui-ci de Cπ vers Ci. It appears from the above that a glucose dialysis assisted by an enzymatic pumping resulting from an enzymatic and cyclic mechanism of phosphorylation / dephosphorylation, on either side of the membrane in the compartments Cπ of arrival and Ci of departure , is quite effective, selective and offers good yields without requiring the use of large volumes of dialysates. This mechanism is further optimized when G-6-P "dephosphorylation is predicted outside of the diffusion layer dπ of the compartment Cπ. Phosphorylation / dephosphorylation take place in d π and di respectively. In all these tests, the membrane is negatively charged like G-6-P "so as to limit its diffusion from C π to Ci.
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU34269/99A AU3426999A (en) | 1998-04-24 | 1999-04-23 | Method for actively and selectively eliminating small molecules by enzymatic pumping: active dialysis |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9805438A FR2777803B1 (en) | 1998-04-24 | 1998-04-24 | PROCESS FOR THE ACTIVE AND SELECTIVE REMOVAL OF SMALL MOLECULES BY ENZYMATIC PUMPING: ACTIVE DIALYSIS |
| FR98/05438 | 1998-04-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1999055828A1 true WO1999055828A1 (en) | 1999-11-04 |
Family
ID=9525861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/FR1999/000970 Ceased WO1999055828A1 (en) | 1998-04-24 | 1999-04-23 | Method for actively and selectively eliminating small molecules by enzymatic pumping: active dialysis |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU3426999A (en) |
| FR (1) | FR2777803B1 (en) |
| WO (1) | WO1999055828A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103830792A (en) * | 2012-11-26 | 2014-06-04 | 贝克顿·迪金森公司 | Glucose management and dialysis method and apparatus |
| WO2020178420A1 (en) | 2019-03-06 | 2020-09-10 | Gambro Lundia Ab | Blood treatment device comprising alkaline phosphatase |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102702309A (en) * | 2012-05-24 | 2012-10-03 | 张力 | Protein microdialyzer and usage method |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3619423A (en) * | 1970-04-20 | 1971-11-09 | Us Health Education & Welfare | Cascade dialysis apparatus and method |
| US4192748A (en) * | 1973-07-05 | 1980-03-11 | Hyden Viktor H | Dialysis apparatus with selective chemical activity |
| EP0273679A2 (en) * | 1986-12-29 | 1988-07-06 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Improved method for effecting enzymatic reactions and an enzymatic reactor useful therein |
| US4956289A (en) * | 1987-03-16 | 1990-09-11 | Brunswick Corporation | Thin film membrane enzyme reactor and method of using same |
| JPH02291282A (en) * | 1989-05-01 | 1990-12-03 | Ngk Insulators Ltd | Two step reaction |
| US5002871A (en) * | 1986-08-18 | 1991-03-26 | The Coca-Cola Company | Enzymatic membrane method for the synthesis and separation of peptides |
| FR2755036A1 (en) * | 1996-10-31 | 1998-04-30 | Univ Claude Bernard Lyon | PROCESS FOR THE SEPARATION AND CONCENTRATION OF SMALL MOLECULES USING MEMBRANE ENZYMATIC PUMPS: SEPARATOR / CONCENTRATE REACTOR |
-
1998
- 1998-04-24 FR FR9805438A patent/FR2777803B1/en not_active Expired - Fee Related
-
1999
- 1999-04-23 WO PCT/FR1999/000970 patent/WO1999055828A1/en not_active Ceased
- 1999-04-23 AU AU34269/99A patent/AU3426999A/en not_active Abandoned
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3619423A (en) * | 1970-04-20 | 1971-11-09 | Us Health Education & Welfare | Cascade dialysis apparatus and method |
| US4192748A (en) * | 1973-07-05 | 1980-03-11 | Hyden Viktor H | Dialysis apparatus with selective chemical activity |
| US5002871A (en) * | 1986-08-18 | 1991-03-26 | The Coca-Cola Company | Enzymatic membrane method for the synthesis and separation of peptides |
| EP0273679A2 (en) * | 1986-12-29 | 1988-07-06 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Improved method for effecting enzymatic reactions and an enzymatic reactor useful therein |
| US4956289A (en) * | 1987-03-16 | 1990-09-11 | Brunswick Corporation | Thin film membrane enzyme reactor and method of using same |
| JPH02291282A (en) * | 1989-05-01 | 1990-12-03 | Ngk Insulators Ltd | Two step reaction |
| FR2755036A1 (en) * | 1996-10-31 | 1998-04-30 | Univ Claude Bernard Lyon | PROCESS FOR THE SEPARATION AND CONCENTRATION OF SMALL MOLECULES USING MEMBRANE ENZYMATIC PUMPS: SEPARATOR / CONCENTRATE REACTOR |
Non-Patent Citations (1)
| Title |
|---|
| DATABASE WPI Section Ch Week 9103, Derwent World Patents Index; Class D16, AN 91-018857, XP002093094 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103830792A (en) * | 2012-11-26 | 2014-06-04 | 贝克顿·迪金森公司 | Glucose management and dialysis method and apparatus |
| JP2014104359A (en) * | 2012-11-26 | 2014-06-09 | Becton Dickinson & Co | Glucose management and dialysis method and apparatus |
| WO2020178420A1 (en) | 2019-03-06 | 2020-09-10 | Gambro Lundia Ab | Blood treatment device comprising alkaline phosphatase |
| CN113543821A (en) * | 2019-03-06 | 2021-10-22 | 甘布罗伦迪亚股份公司 | Blood treatment device containing alkaline phosphatase |
| KR20210136035A (en) * | 2019-03-06 | 2021-11-16 | 감브로 룬디아 아베 | Blood processing device comprising alkaline phosphatase |
| US12186472B2 (en) | 2019-03-06 | 2025-01-07 | Gambro Lundia Ab | Blood treatment device comprising alkaline phosphatase |
| CN113543821B (en) * | 2019-03-06 | 2025-02-14 | 甘布罗伦迪亚股份公司 | Blood processing device containing alkaline phosphatase |
| KR102795670B1 (en) | 2019-03-06 | 2025-04-15 | 감브로 룬디아 아베 | Blood treatment device containing alkaline phosphatase |
| AU2020231463B2 (en) * | 2019-03-06 | 2025-10-09 | Gambro Lundia Ab | Blood treatment device comprising alkaline phosphatase |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2777803A1 (en) | 1999-10-29 |
| FR2777803B1 (en) | 2000-07-28 |
| AU3426999A (en) | 1999-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0409896B1 (en) | Enzymatic electrode and its preparation method | |
| Canh et al. | Construction and study of electrodes using crosslinked enzymes | |
| EP0539280A1 (en) | Process for at least partial dehydration at an aqueous composition and device for carrying out the same | |
| JPS6212847A (en) | Membrane through which liquid and solute can be permeated, manufacture thereof and utilization thereof | |
| Long et al. | Chiral resolution of racemic ibuprofen ester in an enzymatic membrane reactor | |
| FR2570715A1 (en) | PROCESS FOR CARRYING OUT AN ENZYMATIC OR MICROBIAL REACTION | |
| JPH06500258A (en) | Method for reacting reducing or oxidizing substances in aqueous solution and potentiometric cell | |
| WO1999055828A1 (en) | Method for actively and selectively eliminating small molecules by enzymatic pumping: active dialysis | |
| US5057421A (en) | Thin film membrane enzyme/coemzyme reactor and method of using same | |
| Kauffmann et al. | Enzyme electrode biosensors: theory and applications | |
| CH680985A5 (en) | ||
| Yang et al. | Urea permeation and hydrolysis through hollow fiber dialyzer immobilized with urease | |
| Ogbomo et al. | On-line determination of ethanol in bioprocesses based on sample extraction by continuous pervaporation | |
| Tang et al. | Enzyme electrode for amplification of NAD+/NADH using glycerol dehydrogenase and diaphorase with amperometric detection | |
| WO1998018904A1 (en) | Method for separating and concentrating small molecules using enzymatic membrane pumps: separator/concentrator reactor | |
| Chang et al. | Effects of glucose dehydrogenase in converting urea and ammonia into amino acid using artificial cells | |
| WO1990004016A1 (en) | Optrodes with immobilized enzymes | |
| EP2379737A1 (en) | Novel biotracers and uses thereof for controlling filtration plants | |
| EP0247931A1 (en) | Process for the extraction of valuable components from complex solutions, and membrane device for the realization of this process | |
| EP0445043A1 (en) | Biological process for the denitrification of liquid media and apparatus for carrying out the process | |
| FR2826668A1 (en) | Electrochemical reactor adapted for the catalytic transformation of a substrate, contains a semi-permeable filtration membrane, useful for chemical and biochemical syntheses | |
| EP0193420B1 (en) | Device for the determination of compounds having an influence on the cellular oxidation pathway and methods for the determination of these compounds | |
| FR2530962A1 (en) | MEMBRANE FOR CONTROLLING THE PERMEATION OF GLUCOSE THROUGH IT | |
| FR2514782A1 (en) | PROCESS FOR THE PREPARATION OF AQUEOUS SOLUTION, PRACTICALLY FREE OF CELLS, ASPARTASE AND ITS APPLICATION TO THE MANUFACTURE OF ASPARTIC ACID | |
| JPH0225461B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| NENP | Non-entry into the national phase |
Ref country code: KR |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase |